| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | pyrophosphatase activity | KRAS ABCC1 DNAH3 ABCC4 RAP1A RAP1B ABCB7 RAP2A RAP2B NRAS DNAH10 CFTR RSF1 ABCC5 ABCC11 OLA1 BCS1L TRIM23 NUDT3 ABCB8 HRAS ABCD4 DDX53 RAP2C ATP2A1 DNAH6 DNAH9 DYNC1H1 ABCC10 | 5.31e-16 | 839 | 108 | 29 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KRAS ABCC1 DNAH3 ABCC4 RAP1A RAP1B ABCB7 RAP2A RAP2B NRAS DNAH10 CFTR RSF1 ABCC5 ABCC11 OLA1 BCS1L TRIM23 NUDT3 ABCB8 HRAS ABCD4 DDX53 RAP2C ATP2A1 DNAH6 DNAH9 DYNC1H1 ABCC10 | 5.48e-16 | 840 | 108 | 29 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KRAS ABCC1 DNAH3 ABCC4 RAP1A RAP1B ABCB7 RAP2A RAP2B NRAS DNAH10 CFTR RSF1 ABCC5 ABCC11 OLA1 BCS1L TRIM23 NUDT3 ABCB8 HRAS ABCD4 DDX53 RAP2C ATP2A1 DNAH6 DNAH9 DYNC1H1 ABCC10 | 5.48e-16 | 840 | 108 | 29 | GO:0016818 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KRAS ABCC1 DNAH3 ABCC4 RAP1A RAP1B ABCB7 RAP2A RAP2B NRAS DNAH10 CFTR RSF1 ABCC5 ABCC11 OLA1 BCS1L TRIM23 ABCB8 HRAS ABCD4 DDX53 RAP2C ATP2A1 DNAH6 DNAH9 DYNC1H1 ABCC10 | 6.14e-16 | 775 | 108 | 28 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC1 DNAH3 ABCC4 ABCB7 DNAH10 CFTR RSF1 ABCC5 ABCC11 OLA1 BCS1L ABCB8 ABCD4 DDX53 ATP2A1 DNAH6 DNAH9 DYNC1H1 ABCC10 | 2.55e-12 | 441 | 108 | 19 | GO:0016887 |
| GeneOntologyMolecularFunction | ATPase-coupled inorganic anion transmembrane transporter activity | 4.49e-12 | 10 | 108 | 6 | GO:0043225 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.84e-12 | 49 | 108 | 9 | GO:0140359 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | ABCC1 ABCC4 ABCB7 CFTR ABCC5 ABCC11 BCS1L ABCB8 ABCD4 ATP2A1 ABCC10 | 1.70e-11 | 109 | 108 | 11 | GO:0042626 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 DNAH3 ABCC4 ABCB7 DNAH10 CFTR RSF1 ABCC5 ABCC11 OLA1 BCS1L NUBP2 ABCB8 ABCD4 DDX53 ATP2A1 DNAH6 DNAH9 DYNC1H1 ABCC10 | 9.87e-11 | 614 | 108 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | ABCC1 ABCC4 ABCB7 CFTR ABCC5 ABCC11 BCS1L NDUFV1 ABCB8 ABCD4 ATP2A1 ABCC10 | 2.30e-10 | 178 | 108 | 12 | GO:0015399 |
| GeneOntologyMolecularFunction | G protein activity | 9.93e-10 | 59 | 108 | 8 | GO:0003925 | |
| GeneOntologyMolecularFunction | GDP binding | 4.64e-09 | 103 | 108 | 9 | GO:0019003 | |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 1.21e-08 | 15 | 108 | 5 | GO:0008559 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.42e-08 | 18 | 108 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | sulfur compound transmembrane transporter activity | 3.82e-08 | 61 | 108 | 7 | GO:1901682 | |
| GeneOntologyMolecularFunction | ABC-type glutathione S-conjugate transporter activity | 5.57e-08 | 8 | 108 | 4 | GO:0015431 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | GPD2 ABCC4 CYP2A13 FMO5 MAOA ETFA DHRS13 RTN4IP1 CBS PGK1 NDUFV1 RDH11 AASS DECR2 HSD17B10 HSD17B1 HSD17B11 KDSR | 1.45e-07 | 766 | 108 | 18 | GO:0016491 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ABCC1 ABCC4 SLC26A3 ABCB7 CFTR ABCC5 ABCC11 BCS1L NDUFV1 SLC5A6 ABCB8 ABCD4 ATP2A1 ABCC10 | 2.93e-07 | 477 | 108 | 14 | GO:0022804 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 3.75e-07 | 28 | 108 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.04e-06 | 34 | 108 | 5 | GO:0042910 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.60e-06 | 37 | 108 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 4.18e-06 | 171 | 108 | 8 | GO:0015103 | |
| GeneOntologyMolecularFunction | glutathione transmembrane transporter activity | 5.30e-06 | 7 | 108 | 3 | GO:0034634 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.01e-05 | 138 | 108 | 7 | GO:0016614 | |
| GeneOntologyMolecularFunction | GTP binding | KRAS RAP1A RAP1B RAP2A RAP2B NRAS OLA1 TRIM23 GIMAP8 HRAS RAP2C | 1.03e-05 | 397 | 108 | 11 | GO:0005525 |
| GeneOntologyMolecularFunction | tripeptide transmembrane transporter activity | 1.26e-05 | 9 | 108 | 3 | GO:0042937 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 1.26e-05 | 9 | 108 | 3 | GO:0034040 | |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | KRAS RAP1A RAP1B RAP2A RAP2B NRAS OLA1 TRIM23 GIMAP8 HRAS RAP2C | 2.60e-05 | 439 | 108 | 11 | GO:0032561 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | KRAS RAP1A RAP1B RAP2A RAP2B NRAS OLA1 TRIM23 GIMAP8 HRAS RAP2C | 2.60e-05 | 439 | 108 | 11 | GO:0019001 |
| GeneOntologyMolecularFunction | ABC-type vitamin B12 transporter activity | 2.90e-05 | 2 | 108 | 2 | GO:0015420 | |
| GeneOntologyMolecularFunction | CTP synthase activity | 2.90e-05 | 2 | 108 | 2 | GO:0003883 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 2.93e-05 | 33 | 108 | 4 | GO:0072349 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.86e-05 | 70 | 108 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 6.62e-05 | 127 | 108 | 6 | GO:0016616 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 7.73e-05 | 42 | 108 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | efflux transmembrane transporter activity | 8.19e-05 | 16 | 108 | 3 | GO:0015562 | |
| GeneOntologyMolecularFunction | oligopeptide transmembrane transporter activity | 8.19e-05 | 16 | 108 | 3 | GO:0035673 | |
| GeneOntologyMolecularFunction | GTPase activity | 9.86e-05 | 341 | 108 | 9 | GO:0003924 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.29e-04 | 90 | 108 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 1.64e-04 | 20 | 108 | 3 | GO:0004303 | |
| GeneOntologyMolecularFunction | ABC-type bile acid transporter activity | 1.73e-04 | 4 | 108 | 2 | GO:0015432 | |
| GeneOntologyMolecularFunction | ATPase-coupled organic acid transmembrane transporter activity | 1.73e-04 | 4 | 108 | 2 | GO:0033283 | |
| GeneOntologyMolecularFunction | ATPase-coupled monocarboxylic acid transmembrane transporter activity | 1.73e-04 | 4 | 108 | 2 | GO:0033285 | |
| GeneOntologyMolecularFunction | ATPase-coupled carboxylic acid transmembrane transporter activity | 1.73e-04 | 4 | 108 | 2 | GO:0033284 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.93e-04 | 293 | 108 | 8 | GO:0008514 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 2.93e-04 | 59 | 108 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.54e-04 | 118 | 108 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 5.08e-04 | 29 | 108 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | ABCC1 ABCC4 SLC26A3 ABCB7 SLC22A23 CFTR TIMM23 ABCC5 ABCC11 BCS1L NDUFV1 SLC5A6 ABCB8 ABCD4 ATP2A1 ABCC10 | 5.95e-04 | 1180 | 108 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.61e-04 | 73 | 108 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 7.46e-04 | 33 | 108 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 7.46e-04 | 33 | 108 | 3 | GO:0033764 | |
| GeneOntologyMolecularFunction | nerve growth factor binding | 7.94e-04 | 8 | 108 | 2 | GO:0048406 | |
| GeneOntologyMolecularFunction | macromolecule transmembrane transporter activity | 8.15e-04 | 34 | 108 | 3 | GO:0022884 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 9.19e-04 | 207 | 108 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 9.42e-04 | 208 | 108 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 9.65e-04 | 36 | 108 | 3 | GO:0090482 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 1.02e-03 | 9 | 108 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | heme transmembrane transporter activity | 1.02e-03 | 9 | 108 | 2 | GO:0015232 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 1.22e-03 | 39 | 108 | 3 | GO:0016229 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 1.22e-03 | 39 | 108 | 3 | GO:0015605 | |
| GeneOntologyMolecularFunction | transporter activity | ABCC1 ABCC4 SLC26A3 ABCB7 SLC22A23 CFTR TIMM23 ABCC5 ABCC11 BCS1L NDUFV1 SLC5A6 ABCB8 ABCD4 ATP2A1 ABCC10 | 1.51e-03 | 1289 | 108 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 1.54e-03 | 11 | 108 | 2 | GO:0030283 | |
| GeneOntologyMolecularFunction | neurotrophin binding | 1.85e-03 | 12 | 108 | 2 | GO:0043121 | |
| GeneOntologyMolecularFunction | N6-methyladenosine-containing RNA reader activity | 2.91e-03 | 15 | 108 | 2 | GO:1990247 | |
| GeneOntologyMolecularFunction | long-chain fatty acid transmembrane transporter activity | 4.19e-03 | 18 | 108 | 2 | GO:0005324 | |
| GeneOntologyMolecularFunction | NADP binding | 4.62e-03 | 62 | 108 | 3 | GO:0050661 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 4.67e-03 | 19 | 108 | 2 | GO:1990825 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 5.17e-03 | 20 | 108 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | carbohydrate kinase activity | 5.69e-03 | 21 | 108 | 2 | GO:0019200 | |
| GeneOntologyMolecularFunction | fatty acid transmembrane transporter activity | 6.81e-03 | 23 | 108 | 2 | GO:0015245 | |
| GeneOntologyMolecularFunction | NAD binding | 7.27e-03 | 73 | 108 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 7.40e-03 | 24 | 108 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | ABCC1 ABCC4 SLC26A3 CFTR ABCC5 ABCC11 NDUFV1 SLC5A6 ATP2A1 ABCC10 | 8.00e-03 | 758 | 108 | 10 | GO:0015318 |
| GeneOntologyMolecularFunction | triacylglycerol lipase activity | 8.65e-03 | 26 | 108 | 2 | GO:0004806 | |
| GeneOntologyMolecularFunction | protein transmembrane transporter activity | 1.00e-02 | 28 | 108 | 2 | GO:0008320 | |
| GeneOntologyBiologicalProcess | Rap protein signal transduction | 5.99e-09 | 14 | 105 | 5 | GO:0032486 | |
| GeneOntologyBiologicalProcess | leukotriene transport | 2.19e-08 | 7 | 105 | 4 | GO:0071716 | |
| GeneOntologyBiologicalProcess | small molecule catabolic process | GPD2 HK1 ETFA PFKM CBS PGK1 MTAP NUDT3 AASS ABCD4 DECR2 IRS2 HSD17B10 | 2.26e-07 | 421 | 105 | 13 | GO:0044282 |
| GeneOntologyBiologicalProcess | carboxylic acid metabolic process | ABCC1 CYP2A13 HK1 ETFA PFKM CBS PGK1 ENO4 LIPC CTPS2 MTAP AASS SLC5A6 ABCD4 DECR2 IRS2 HSD17B10 CTPS1 TNXB ABCC10 | 2.32e-07 | 1035 | 105 | 20 | GO:0019752 |
| GeneOntologyBiologicalProcess | microvillus assembly | 2.78e-07 | 28 | 105 | 5 | GO:0030033 | |
| GeneOntologyBiologicalProcess | oxoacid metabolic process | ABCC1 CYP2A13 HK1 ETFA PFKM CBS PGK1 ENO4 LIPC CTPS2 MTAP AASS SLC5A6 ABCD4 DECR2 IRS2 HSD17B10 CTPS1 TNXB ABCC10 | 3.29e-07 | 1058 | 105 | 20 | GO:0043436 |
| GeneOntologyBiologicalProcess | organic acid metabolic process | ABCC1 CYP2A13 HK1 ETFA PFKM CBS PGK1 ENO4 LIPC CTPS2 MTAP AASS SLC5A6 ABCD4 DECR2 IRS2 HSD17B10 CTPS1 TNXB ABCC10 | 3.59e-07 | 1064 | 105 | 20 | GO:0006082 |
| GeneOntologyBiologicalProcess | microvillus organization | 7.68e-07 | 34 | 105 | 5 | GO:0032528 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.16e-06 | 153 | 105 | 8 | GO:0098656 | |
| GeneOntologyBiologicalProcess | tetrapyrrole metabolic process | 1.95e-06 | 73 | 105 | 6 | GO:0033013 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 4.41e-06 | 183 | 105 | 8 | GO:0006820 | |
| GeneOntologyBiologicalProcess | glutathione transmembrane transport | 7.05e-06 | 8 | 105 | 3 | GO:0034775 | |
| GeneOntologyBiologicalProcess | heme metabolic process | 8.06e-06 | 54 | 105 | 5 | GO:0042168 | |
| GeneOntologyBiologicalProcess | regulation of heme biosynthetic process | 1.05e-05 | 9 | 105 | 3 | GO:0070453 | |
| GeneOntologyBiologicalProcess | regulation of tetrapyrrole biosynthetic process | 1.05e-05 | 9 | 105 | 3 | GO:1901463 | |
| GeneOntologyBiologicalProcess | regulation of tetrapyrrole metabolic process | 1.50e-05 | 10 | 105 | 3 | GO:1901401 | |
| GeneOntologyBiologicalProcess | tripeptide transmembrane transport | 1.50e-05 | 10 | 105 | 3 | GO:0035443 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound metabolic process | 1.73e-05 | 63 | 105 | 5 | GO:0006778 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 1.81e-05 | 222 | 105 | 8 | GO:0071466 | |
| GeneOntologyBiologicalProcess | xenobiotic transport | 1.87e-05 | 64 | 105 | 5 | GO:0042908 | |
| GeneOntologyBiologicalProcess | sulfur compound transport | 2.01e-05 | 65 | 105 | 5 | GO:0072348 | |
| GeneOntologyBiologicalProcess | cyclic nucleotide transport | 2.05e-05 | 11 | 105 | 3 | GO:0070729 | |
| GeneOntologyBiologicalProcess | glutathione transport | 2.05e-05 | 11 | 105 | 3 | GO:0034635 | |
| GeneOntologyBiologicalProcess | cAMP transport | 2.57e-05 | 2 | 105 | 2 | GO:0070730 | |
| GeneOntologyBiologicalProcess | 'de novo' CTP biosynthetic process | 2.57e-05 | 2 | 105 | 2 | GO:0044210 | |
| GeneOntologyBiologicalProcess | nucleobase-containing small molecule metabolic process | GPD2 HK1 FMO5 OLA1 PFKM PGK1 NDUFV1 ENO4 CTPS2 MTAP NUDT3 AASS CTPS1 GMPPA | 3.43e-05 | 767 | 105 | 14 | GO:0055086 |
| GeneOntologyBiologicalProcess | tripeptide transport | 3.53e-05 | 13 | 105 | 3 | GO:0042939 | |
| GeneOntologyBiologicalProcess | fatty acid beta-oxidation | 5.51e-05 | 80 | 105 | 5 | GO:0006635 | |
| GeneOntologyBiologicalProcess | NADH metabolic process | 6.12e-05 | 42 | 105 | 4 | GO:0006734 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 7.36e-05 | 44 | 105 | 4 | GO:0072337 | |
| GeneOntologyBiologicalProcess | oligopeptide transmembrane transport | 8.28e-05 | 17 | 105 | 3 | GO:0035672 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | CYP2A13 HK1 ETFA PFKM PGK1 ENO4 LIPC SLC5A6 ABCD4 DECR2 IRS2 HSD17B10 TNXB | 8.69e-05 | 731 | 105 | 13 | GO:0032787 |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | KRAS RAP1A RAP1B RAP2A PSD2 RAP2B NRAS HRAS LRP4 RAP2C PLXNB1 | 9.36e-05 | 538 | 105 | 11 | GO:0007264 |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 1.00e-04 | 210 | 105 | 7 | GO:0072524 | |
| GeneOntologyBiologicalProcess | ribonucleoside triphosphate metabolic process | 1.19e-04 | 290 | 105 | 8 | GO:0009199 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 1.19e-04 | 94 | 105 | 5 | GO:0042440 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 1.22e-04 | 50 | 105 | 4 | GO:0006862 | |
| GeneOntologyBiologicalProcess | cellular response to cAMP | 1.53e-04 | 53 | 105 | 4 | GO:0071320 | |
| GeneOntologyBiologicalProcess | NADH regeneration | 1.59e-04 | 21 | 105 | 3 | GO:0006735 | |
| GeneOntologyBiologicalProcess | canonical glycolysis | 1.59e-04 | 21 | 105 | 3 | GO:0061621 | |
| GeneOntologyBiologicalProcess | glucose catabolic process to pyruvate | 1.59e-04 | 21 | 105 | 3 | GO:0061718 | |
| GeneOntologyBiologicalProcess | nucleoside triphosphate metabolic process | 1.76e-04 | 307 | 105 | 8 | GO:0009141 | |
| GeneOntologyBiologicalProcess | fatty acid transmembrane transport | 1.84e-04 | 22 | 105 | 3 | GO:1902001 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | GPD2 HK1 FMO5 OLA1 PFKM PGK1 NDUFV1 ENO4 CTPS2 NUDT3 AASS CTPS1 | 1.87e-04 | 684 | 105 | 12 | GO:0009117 |
| GeneOntologyBiologicalProcess | vitamin transport | 1.90e-04 | 56 | 105 | 4 | GO:0051180 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | GPD2 HK1 FMO5 OLA1 PFKM PGK1 NDUFV1 ENO4 CTPS2 NUDT3 AASS CTPS1 | 2.06e-04 | 691 | 105 | 12 | GO:0006753 |
| GeneOntologyBiologicalProcess | oligopeptide transport | 2.11e-04 | 23 | 105 | 3 | GO:0006857 | |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 2.18e-04 | 58 | 105 | 4 | GO:0061028 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 2.48e-04 | 410 | 105 | 9 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 2.57e-04 | 412 | 105 | 9 | GO:0015849 | |
| GeneOntologyBiologicalProcess | NAD catabolic process | 2.72e-04 | 25 | 105 | 3 | GO:0019677 | |
| GeneOntologyBiologicalProcess | glycolytic process through glucose-6-phosphate | 2.72e-04 | 25 | 105 | 3 | GO:0061620 | |
| GeneOntologyBiologicalProcess | amide transport | 2.96e-04 | 420 | 105 | 9 | GO:0042886 | |
| GeneOntologyBiologicalProcess | organic anion transport | ABCC1 ABCC4 SLC26A3 CFTR ABCC5 ABCC11 SLC5A6 ABCD4 IRS2 ABCC10 | 2.99e-04 | 515 | 105 | 10 | GO:0015711 |
| GeneOntologyBiologicalProcess | fatty acid catabolic process | 3.18e-04 | 116 | 105 | 5 | GO:0009062 | |
| GeneOntologyBiologicalProcess | response to xenobiotic stimulus | 3.48e-04 | 525 | 105 | 10 | GO:0009410 | |
| GeneOntologyBiologicalProcess | generation of precursor metabolites and energy | 3.69e-04 | 529 | 105 | 10 | GO:0006091 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic vesicle exocytosis | 3.80e-04 | 6 | 105 | 2 | GO:2000301 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 3.91e-04 | 533 | 105 | 10 | GO:0009259 | |
| GeneOntologyBiologicalProcess | fatty acid oxidation | 4.02e-04 | 122 | 105 | 5 | GO:0019395 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 4.17e-04 | 123 | 105 | 5 | GO:0072526 | |
| GeneOntologyBiologicalProcess | positive regulation of protein autophosphorylation | 4.25e-04 | 29 | 105 | 3 | GO:0031954 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 4.34e-04 | 540 | 105 | 10 | GO:0019693 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 4.87e-04 | 272 | 105 | 7 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 4.87e-04 | 272 | 105 | 7 | GO:0046395 | |
| GeneOntologyBiologicalProcess | purine-containing compound metabolic process | 4.89e-04 | 652 | 105 | 11 | GO:0072521 | |
| GeneOntologyBiologicalProcess | lipid oxidation | 5.19e-04 | 129 | 105 | 5 | GO:0034440 | |
| GeneOntologyBiologicalProcess | glycolytic process through fructose-6-phosphate | 5.19e-04 | 31 | 105 | 3 | GO:0061615 | |
| GeneOntologyBiologicalProcess | icosanoid transport | 5.27e-04 | 73 | 105 | 4 | GO:0071715 | |
| GeneOntologyBiologicalProcess | GDP-mannose biosynthetic process | 5.30e-04 | 7 | 105 | 2 | GO:0009298 | |
| GeneOntologyBiologicalProcess | negative regulation of regulated secretory pathway | 5.71e-04 | 32 | 105 | 3 | GO:1903306 | |
| GeneOntologyBiologicalProcess | glucose catabolic process | 5.71e-04 | 32 | 105 | 3 | GO:0006007 | |
| GeneOntologyBiologicalProcess | NAD metabolic process | 5.84e-04 | 75 | 105 | 4 | GO:0019674 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 5.90e-04 | 202 | 105 | 6 | GO:0046496 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 5.90e-04 | 202 | 105 | 6 | GO:0019362 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | GPD2 CFTR RTN4IP1 CBS PGK1 LIPC MTAP AASS DECR2 HSD17B10 HSD17B1 | 6.59e-04 | 676 | 105 | 11 | GO:0044283 |
| GeneOntologyBiologicalProcess | heme biosynthetic process | 6.84e-04 | 34 | 105 | 3 | GO:0006783 | |
| GeneOntologyBiologicalProcess | intracellular pH elevation | 7.05e-04 | 8 | 105 | 2 | GO:0051454 | |
| GeneOntologyBiologicalProcess | pyrimidine nucleobase biosynthetic process | 7.05e-04 | 8 | 105 | 2 | GO:0019856 | |
| GeneOntologyBiologicalProcess | endothelial cell development | 7.45e-04 | 80 | 105 | 4 | GO:0001885 | |
| GeneOntologyBiologicalProcess | lipid catabolic process | 7.52e-04 | 382 | 105 | 8 | GO:0016042 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 7.76e-04 | 141 | 105 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 7.78e-04 | 213 | 105 | 6 | GO:0015718 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid catabolic process | 8.80e-04 | 145 | 105 | 5 | GO:0072329 | |
| GeneOntologyBiologicalProcess | heme transport | 9.03e-04 | 9 | 105 | 2 | GO:0015886 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 1.02e-03 | 87 | 105 | 4 | GO:0150104 | |
| GeneOntologyBiologicalProcess | porphyrin-containing compound biosynthetic process | 1.03e-03 | 39 | 105 | 3 | GO:0006779 | |
| GeneOntologyBiologicalProcess | tetrapyrrole biosynthetic process | 1.03e-03 | 39 | 105 | 3 | GO:0033014 | |
| GeneOntologyBiologicalProcess | vascular transport | 1.07e-03 | 88 | 105 | 4 | GO:0010232 | |
| GeneOntologyBiologicalProcess | lipid transport | 1.12e-03 | 506 | 105 | 9 | GO:0006869 | |
| GeneOntologyBiologicalProcess | cobalamin transport | 1.12e-03 | 10 | 105 | 2 | GO:0015889 | |
| GeneOntologyBiologicalProcess | purine nucleotide metabolic process | 1.23e-03 | 619 | 105 | 10 | GO:0006163 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 1.24e-03 | 233 | 105 | 6 | GO:0017157 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 1.26e-03 | 92 | 105 | 4 | GO:0051057 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | GPD2 HK1 ABCC5 OLA1 PFKM PGK1 NDUFV1 ENO4 LIPC CTPS2 MTAP NUDT3 AASS CTPS1 GMPPA | 1.35e-03 | 1226 | 105 | 15 | GO:1901135 |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion-dependent exocytosis | 1.37e-03 | 11 | 105 | 2 | GO:0045955 | |
| GeneOntologyBiologicalProcess | GDP-mannose metabolic process | 1.37e-03 | 11 | 105 | 2 | GO:0019673 | |
| GeneOntologyBiologicalProcess | guanine nucleotide transport | 1.37e-03 | 11 | 105 | 2 | GO:0001408 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.46e-03 | 44 | 105 | 3 | GO:0015865 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 1.48e-03 | 163 | 105 | 5 | GO:1905039 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 7.55e-06 | 25 | 107 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | dynein complex | 8.28e-06 | 54 | 107 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.52e-05 | 10 | 107 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | 9+2 motile cilium | 3.10e-05 | 238 | 107 | 8 | GO:0097729 | |
| GeneOntologyCellularComponent | mitochondrial membrane | GPD2 KRAS ABCB7 HK1 MAOA VPS13C TIMM23 RTN4IP1 TMEM14DP BCS1L NDUFV1 ABCB8 TMEM14B HSD17B10 UQCRC2 | 3.47e-05 | 866 | 107 | 15 | GO:0031966 |
| GeneOntologyCellularComponent | mitochondrial envelope | GPD2 KRAS ABCB7 HK1 MAOA VPS13C TIMM23 RTN4IP1 TMEM14DP BCS1L NDUFV1 ABCB8 TMEM14B HSD17B10 UQCRC2 | 6.24e-05 | 912 | 107 | 15 | GO:0005740 |
| GeneOntologyCellularComponent | cytoophidium | 7.76e-05 | 3 | 107 | 2 | GO:0097268 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.81e-04 | 161 | 107 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | apical plasma membrane | 2.01e-04 | 487 | 107 | 10 | GO:0016324 | |
| GeneOntologyCellularComponent | subapical complex | 2.57e-04 | 5 | 107 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | vacuolar membrane | RAP1B VPS13C CFTR ABCC11 TRIM23 SORT1 AP5B1 ABCD4 KICS2 ABCC10 | 2.77e-04 | 507 | 107 | 10 | GO:0005774 |
| GeneOntologyCellularComponent | secretory granule membrane | 2.92e-04 | 329 | 107 | 8 | GO:0030667 | |
| GeneOntologyCellularComponent | organelle envelope | GPD2 KRAS ABCB7 HK1 MAOA VPS13C TIMM23 RTN4IP1 TMEM14DP BCS1L NDUFV1 SORT1 INTS2 ABCB8 TMEM14B HSD17B10 UQCRC2 DYNC1H1 | 3.43e-04 | 1435 | 107 | 18 | GO:0031967 |
| GeneOntologyCellularComponent | ATP-binding cassette (ABC) transporter complex | 3.84e-04 | 6 | 107 | 2 | GO:0043190 | |
| GeneOntologyCellularComponent | motile cilium | 4.84e-04 | 355 | 107 | 8 | GO:0031514 | |
| GeneOntologyCellularComponent | tertiary granule membrane | 5.38e-04 | 73 | 107 | 4 | GO:0070821 | |
| GeneOntologyCellularComponent | lysosomal membrane | 6.16e-04 | 462 | 107 | 9 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 6.16e-04 | 462 | 107 | 9 | GO:0098852 | |
| GeneOntologyCellularComponent | apical part of cell | 9.22e-04 | 592 | 107 | 10 | GO:0045177 | |
| GeneOntologyCellularComponent | mitochondrial inner membrane | GPD2 ABCB7 TIMM23 TMEM14DP BCS1L NDUFV1 ABCB8 TMEM14B HSD17B10 UQCRC2 | 9.33e-04 | 593 | 107 | 10 | GO:0005743 |
| GeneOntologyCellularComponent | organelle inner membrane | GPD2 ABCB7 TIMM23 TMEM14DP BCS1L NDUFV1 ABCB8 TMEM14B HSD17B10 UQCRC2 | 1.89e-03 | 652 | 107 | 10 | GO:0019866 |
| GeneOntologyCellularComponent | cilium | DNAH3 ABCC4 RAP1A SLC26A3 DNAH10 ADGRV1 PFKM NUBP2 ENO4 RDH11 DNAH6 DNAH9 | 2.15e-03 | 898 | 107 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | respiratory chain complex III | 2.61e-03 | 15 | 107 | 2 | GO:0045275 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.64e-03 | 112 | 107 | 4 | GO:0055038 | |
| HumanPheno | Linear nevus sebaceous | 7.86e-07 | 3 | 48 | 3 | HP:0010817 | |
| HumanPheno | Nevus sebaceous | 7.75e-06 | 5 | 48 | 3 | HP:0010815 | |
| Domain | - | KRAS ABCC1 DNAH3 ABCC4 RAP1A RAP1B ABCB7 RAP2A RAP2B NRAS DNAH10 CFTR ABCC5 ABCC11 OLA1 BCS1L TRIM23 NUBP2 CTPS2 GIMAP8 ABCB8 HRAS ABCD4 DDX53 CTPS1 RAP2C DNAH6 DNAH9 DYNC1H1 ABCC10 | 6.00e-18 | 746 | 105 | 30 | 3.40.50.300 |
| Domain | P-loop_NTPase | KRAS ABCC1 DNAH3 ABCC4 RAP1A RAP1B ABCB7 RAP2A RAP2B NRAS DNAH10 CFTR ABCC5 ABCC11 OLA1 BCS1L TRIM23 NUBP2 CTPS2 GIMAP8 ABCB8 HRAS ABCD4 DDX53 CTPS1 RAP2C DNAH6 DNAH9 DYNC1H1 ABCC10 | 2.00e-16 | 848 | 105 | 30 | IPR027417 |
| Domain | AAA+_ATPase | ABCC1 DNAH3 ABCC4 ABCB7 DNAH10 CFTR ABCC5 ABCC11 BCS1L ABCB8 ABCD4 DNAH6 DNAH9 DYNC1H1 ABCC10 | 2.96e-15 | 144 | 105 | 15 | IPR003593 |
| Domain | AAA | ABCC1 DNAH3 ABCC4 ABCB7 DNAH10 CFTR ABCC5 ABCC11 BCS1L ABCB8 ABCD4 DNAH6 DNAH9 DYNC1H1 ABCC10 | 2.96e-15 | 144 | 105 | 15 | SM00382 |
| Domain | ABC_TM1F | 2.50e-14 | 28 | 105 | 9 | PS50929 | |
| Domain | ABC1_TM_dom | 2.50e-14 | 28 | 105 | 9 | IPR011527 | |
| Domain | ABC_membrane | 5.19e-13 | 24 | 105 | 8 | PF00664 | |
| Domain | ABC_transporter_CS | 1.51e-12 | 42 | 105 | 9 | IPR017871 | |
| Domain | ABC_tran | 5.53e-12 | 48 | 105 | 9 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.53e-12 | 48 | 105 | 9 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 6.74e-12 | 49 | 105 | 9 | PS00211 | |
| Domain | ABC_transporter-like | 8.18e-12 | 50 | 105 | 9 | IPR003439 | |
| Domain | RAS | 1.58e-11 | 35 | 105 | 8 | PS51421 | |
| Domain | Small_GTPase_Ras | 2.57e-11 | 37 | 105 | 8 | IPR020849 | |
| Domain | Dynein_heavy_chain_D4_dom | 9.81e-09 | 14 | 105 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 9.81e-09 | 14 | 105 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 9.81e-09 | 14 | 105 | 5 | IPR013602 | |
| Domain | DHC_N2 | 9.81e-09 | 14 | 105 | 5 | PF08393 | |
| Domain | MT | 9.81e-09 | 14 | 105 | 5 | PF12777 | |
| Domain | AAA_8 | 9.81e-09 | 14 | 105 | 5 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 9.81e-09 | 14 | 105 | 5 | IPR011704 | |
| Domain | AAA_5 | 9.81e-09 | 14 | 105 | 5 | PF07728 | |
| Domain | DHC_fam | 1.46e-08 | 15 | 105 | 5 | IPR026983 | |
| Domain | Dynein_heavy_dom | 1.46e-08 | 15 | 105 | 5 | IPR004273 | |
| Domain | Dynein_heavy | 1.46e-08 | 15 | 105 | 5 | PF03028 | |
| Domain | ADH_SHORT | 1.81e-08 | 53 | 105 | 7 | PS00061 | |
| Domain | adh_short | 2.36e-08 | 55 | 105 | 7 | PF00106 | |
| Domain | SDR_fam | 2.68e-08 | 56 | 105 | 7 | IPR002347 | |
| Domain | - | FMO5 DHRS13 RTN4IP1 RDH11 AASS DECR2 HSD17B10 HSD17B1 HSD17B11 KDSR | 3.88e-08 | 169 | 105 | 10 | 3.40.50.720 |
| Domain | NAD(P)-bd_dom | FMO5 DHRS13 RTN4IP1 RDH11 AASS DECR2 HSD17B10 HSD17B1 HSD17B11 KDSR | 4.84e-08 | 173 | 105 | 10 | IPR016040 |
| Domain | Small_GTPase | 2.95e-07 | 160 | 105 | 9 | IPR001806 | |
| Domain | Small_GTP-bd_dom | 4.24e-07 | 167 | 105 | 9 | IPR005225 | |
| Domain | Ras | 9.90e-07 | 136 | 105 | 8 | PF00071 | |
| Domain | KH_1 | 2.21e-06 | 38 | 105 | 5 | PF00013 | |
| Domain | - | 2.52e-06 | 39 | 105 | 5 | 3.30.1370.10 | |
| Domain | KH | 2.87e-06 | 40 | 105 | 5 | SM00322 | |
| Domain | KH_dom | 2.87e-06 | 40 | 105 | 5 | IPR004087 | |
| Domain | KH_TYPE_1 | 3.68e-06 | 42 | 105 | 5 | PS50084 | |
| Domain | KH_dom_type_1 | 4.65e-06 | 44 | 105 | 5 | IPR004088 | |
| Domain | DHC_N1 | 9.47e-06 | 8 | 105 | 3 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 9.47e-06 | 8 | 105 | 3 | IPR013594 | |
| Domain | CFTR/ABCC7 | 3.13e-05 | 2 | 105 | 2 | IPR009147 | |
| Domain | L27_2 | 3.13e-05 | 2 | 105 | 2 | PF09045 | |
| Domain | CTP_synthase_N | 3.13e-05 | 2 | 105 | 2 | IPR017456 | |
| Domain | GATase1_CTP_Synthase | 3.13e-05 | 2 | 105 | 2 | IPR033828 | |
| Domain | L27_2 | 3.13e-05 | 2 | 105 | 2 | IPR015132 | |
| Domain | CTP_synthase | 3.13e-05 | 2 | 105 | 2 | IPR004468 | |
| Domain | CTP_synth_N | 3.13e-05 | 2 | 105 | 2 | PF06418 | |
| Domain | GATase | 3.10e-04 | 5 | 105 | 2 | PF00117 | |
| Domain | TMEM14 | 3.10e-04 | 5 | 105 | 2 | IPR005349 | |
| Domain | Tmemb_14 | 3.10e-04 | 5 | 105 | 2 | PF03647 | |
| Domain | GATASE | 4.63e-04 | 6 | 105 | 2 | IPR017926 | |
| Domain | GATASE_TYPE_1 | 4.63e-04 | 6 | 105 | 2 | PS51273 | |
| Domain | Sc_DH/Rdtase_CS | 9.91e-04 | 35 | 105 | 3 | IPR020904 | |
| Domain | - | 1.37e-03 | 10 | 105 | 2 | 3.40.50.880 | |
| Domain | Lipase/vitellogenin | 1.37e-03 | 10 | 105 | 2 | IPR013818 | |
| Domain | TAG_lipase | 1.37e-03 | 10 | 105 | 2 | IPR000734 | |
| Domain | Lipase_LIPH | 1.37e-03 | 10 | 105 | 2 | IPR016272 | |
| Domain | Lipase | 1.37e-03 | 10 | 105 | 2 | PF00151 | |
| Domain | Lipase_N | 1.37e-03 | 10 | 105 | 2 | IPR033906 | |
| Domain | Class_I_gatase-like | 1.99e-03 | 12 | 105 | 2 | IPR029062 | |
| Domain | L27 | 2.35e-03 | 13 | 105 | 2 | SM00569 | |
| Domain | L27 | 2.35e-03 | 13 | 105 | 2 | PS51022 | |
| Domain | L27_dom | 2.35e-03 | 13 | 105 | 2 | IPR004172 | |
| Domain | Bbox_C | 3.13e-03 | 15 | 105 | 2 | IPR003649 | |
| Domain | BBC | 3.13e-03 | 15 | 105 | 2 | SM00502 | |
| Domain | - | 3.86e-03 | 56 | 105 | 3 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 4.05e-03 | 57 | 105 | 3 | IPR023753 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 4.07e-12 | 44 | 85 | 9 | M11911 | |
| Pathway | REACTOME_SOS_MEDIATED_SIGNALLING | 4.25e-08 | 7 | 85 | 4 | M19489 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 1.87e-07 | 103 | 85 | 8 | M758 | |
| Pathway | WP_RALA_DOWNSTREAM_REGULATED_GENES | 5.87e-07 | 12 | 85 | 4 | M39408 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS | 1.18e-06 | 14 | 85 | 4 | M27908 | |
| Pathway | PID_MAPK_TRK_PATHWAY | 1.72e-06 | 34 | 85 | 5 | M270 | |
| Pathway | REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS | 2.10e-06 | 5 | 85 | 3 | M26921 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 2.15e-06 | 99 | 85 | 7 | MM14986 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 3.94e-06 | 40 | 85 | 5 | M27557 | |
| Pathway | PID_EPHB_FWD_PATHWAY | 3.94e-06 | 40 | 85 | 5 | M62 | |
| Pathway | REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ | 4.18e-06 | 6 | 85 | 3 | M27951 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY | 4.18e-06 | 6 | 85 | 3 | M47433 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX | 4.18e-06 | 6 | 85 | 3 | M47931 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1 | 4.18e-06 | 6 | 85 | 3 | M47932 | |
| Pathway | REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS | 7.15e-06 | 45 | 85 | 5 | M27623 | |
| Pathway | REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS | 7.28e-06 | 7 | 85 | 3 | M29717 | |
| Pathway | KEGG_NEUROTROPHIN_SIGNALING_PATHWAY | 1.07e-05 | 126 | 85 | 7 | M16763 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP | 1.16e-05 | 8 | 85 | 3 | M47935 | |
| Pathway | REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS | 1.16e-05 | 8 | 85 | 3 | M27919 | |
| Pathway | REACTOME_SIGNALING_BY_ERYTHROPOIETIN | 1.41e-05 | 25 | 85 | 4 | M27865 | |
| Pathway | REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN | 1.73e-05 | 9 | 85 | 3 | M27156 | |
| Pathway | REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R | 1.73e-05 | 9 | 85 | 3 | M27173 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS | 1.73e-05 | 9 | 85 | 3 | M27904 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.94e-05 | 27 | 85 | 4 | M47755 | |
| Pathway | WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA | 2.74e-05 | 59 | 85 | 5 | M39750 | |
| Pathway | PID_TRKR_PATHWAY | 3.23e-05 | 61 | 85 | 5 | M187 | |
| Pathway | REACTOME_MET_ACTIVATES_RAS_SIGNALING | 3.37e-05 | 11 | 85 | 3 | M27740 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE | 3.37e-05 | 11 | 85 | 3 | M27535 | |
| Pathway | KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.37e-05 | 11 | 85 | 3 | M47370 | |
| Pathway | KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 3.37e-05 | 11 | 85 | 3 | M47371 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2 | 3.37e-05 | 11 | 85 | 3 | M29814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY | 3.37e-05 | 11 | 85 | 3 | M47436 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY | 3.37e-05 | 11 | 85 | 3 | M47432 | |
| Pathway | REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3 | 3.37e-05 | 11 | 85 | 3 | M27911 | |
| Pathway | REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS | 4.40e-05 | 65 | 85 | 5 | M38994 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 4.48e-05 | 12 | 85 | 3 | M47369 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY | 4.48e-05 | 12 | 85 | 3 | M47815 | |
| Pathway | REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS | 4.48e-05 | 12 | 85 | 3 | M29851 | |
| Pathway | WP_AEROBIC_GLYCOLYSIS | 4.48e-05 | 12 | 85 | 3 | M39816 | |
| Pathway | REACTOME_SIGNALLING_TO_ERKS | 4.97e-05 | 34 | 85 | 4 | M13881 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY | 5.79e-05 | 13 | 85 | 3 | M47594 | |
| Pathway | WP_AEROBIC_GLYCOLYSIS_AUGMENTED | 5.79e-05 | 13 | 85 | 3 | M48331 | |
| Pathway | REACTOME_P38MAPK_EVENTS | 5.79e-05 | 13 | 85 | 3 | M1441 | |
| Pathway | KEGG_RENAL_CELL_CARCINOMA | 6.30e-05 | 70 | 85 | 5 | M13266 | |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 6.30e-05 | 70 | 85 | 5 | M3115 | |
| Pathway | REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES | 7.34e-05 | 14 | 85 | 3 | M27734 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY | 7.34e-05 | 14 | 85 | 3 | M47364 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY | 7.34e-05 | 14 | 85 | 3 | M47365 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY | 7.34e-05 | 14 | 85 | 3 | M47366 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 7.34e-05 | 14 | 85 | 3 | M47390 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 7.34e-05 | 14 | 85 | 3 | M47378 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING | 7.34e-05 | 14 | 85 | 3 | M569 | |
| Pathway | PID_TCR_RAS_PATHWAY | 7.34e-05 | 14 | 85 | 3 | M134 | |
| Pathway | KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 7.34e-05 | 14 | 85 | 3 | M47488 | |
| Pathway | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | 7.34e-05 | 14 | 85 | 3 | M719 | |
| Pathway | REACTOME_MAP2K_AND_MAPK_ACTIVATION | 8.62e-05 | 39 | 85 | 4 | MM15272 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII | 9.14e-05 | 15 | 85 | 3 | M29701 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47367 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47389 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47375 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47592 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47593 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47640 | |
| Pathway | KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47485 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47473 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47474 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47475 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47480 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47495 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47496 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47497 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47472 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47535 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY | 9.14e-05 | 15 | 85 | 3 | M47531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY | 1.12e-04 | 16 | 85 | 3 | M47363 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY | 1.12e-04 | 16 | 85 | 3 | M47373 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY | 1.12e-04 | 16 | 85 | 3 | M47381 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY | 1.12e-04 | 16 | 85 | 3 | M47804 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY | 1.12e-04 | 16 | 85 | 3 | M47801 | |
| Pathway | REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING | 1.12e-04 | 16 | 85 | 3 | M562 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS | 1.12e-04 | 16 | 85 | 3 | M29847 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY | 1.12e-04 | 16 | 85 | 3 | M47483 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS | 1.12e-04 | 16 | 85 | 3 | M41733 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY | 1.12e-04 | 16 | 85 | 3 | M47682 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.12e-04 | 79 | 85 | 5 | M27643 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.27e-04 | 43 | 85 | 4 | M47669 | |
| Pathway | REACTOME_ONCOGENIC_MAPK_SIGNALING | 1.34e-04 | 82 | 85 | 5 | M27626 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY | 1.35e-04 | 17 | 85 | 3 | M47376 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY | 1.35e-04 | 17 | 85 | 3 | M47684 | |
| Pathway | REACTOME_SIGNALING_BY_NTRK3_TRKC | 1.35e-04 | 17 | 85 | 3 | M27918 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.52e-04 | 45 | 85 | 4 | M47670 | |
| Pathway | REACTOME_SHC_MEDIATED_CASCADE_FGFR3 | 1.62e-04 | 18 | 85 | 3 | M27518 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 1.62e-04 | 18 | 85 | 3 | M39737 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 1.62e-04 | 18 | 85 | 3 | M657 | |
| Pathway | REACTOME_TIE2_SIGNALING | 1.62e-04 | 18 | 85 | 3 | M11932 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY | 1.91e-04 | 19 | 85 | 3 | M47793 | |
| Pathway | REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS | 1.91e-04 | 19 | 85 | 3 | M559 | |
| Pathway | REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION | 1.91e-04 | 19 | 85 | 3 | M27423 | |
| Pathway | REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS | 1.91e-04 | 19 | 85 | 3 | M41732 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | A2M RAP1B HK1 ETFA OLA1 ECPAS BCS1L CBS PGK1 IGF2BP1 MTAP RDH11 SLC4A1AP AASS HSD17B10 UQCRC2 CTPS1 FUBP3 | 6.73e-13 | 607 | 109 | 18 | 39147351 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | KRAS RAP1A RAP1B ABCB7 HK1 NRAS POLR1A ETFA TIMM23 PFKM CBS NUBP2 IGF2BP1 CTPS2 AASS HRAS HSD17B10 UQCRC2 CTPS1 HSD17B11 GMPPA FUBP3 DYNC1H1 | 6.63e-12 | 1257 | 109 | 23 | 37317656 |
| Pubmed | ABCC1 ABCC4 CYP2A13 ABCB7 CFTR ABCC5 NDUFV1 ABCB8 ABCD4 HSD17B10 ABCC10 | 2.76e-11 | 193 | 109 | 11 | 19343046 | |
| Pubmed | Identification of 18 mouse ABC genes and characterization of the ABC superfamily in Mus musculus. | 7.97e-11 | 23 | 109 | 6 | 10708515 | |
| Pubmed | Rap2, but not Rap1 GTPase is expressed in human red blood cells and is involved in vesiculation. | 9.13e-11 | 4 | 109 | 4 | 16540189 | |
| Pubmed | 9.13e-11 | 4 | 109 | 4 | 11175280 | ||
| Pubmed | SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. | 1.25e-10 | 11 | 109 | 5 | 28263956 | |
| Pubmed | Rap2A links intestinal cell polarity to brush border formation. | 8.07e-10 | 15 | 109 | 5 | 22797597 | |
| Pubmed | 1.36e-09 | 6 | 109 | 4 | 9753431 | ||
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | RAP2B POLR1A NEK6 ETFA TIMM23 PFKM CTPS2 UQCRC2 CTPS1 RAP2C HSD17B11 GMPPA ATP2A1 DYNC1H1 | 2.97e-09 | 565 | 109 | 14 | 33567341 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | GPD2 RAP1B HK1 POLR1A DNAH10 VPS13C PCLO ETFA OLA1 PFKM ECPAS CBS PGK1 NDUFV1 IGF2BP1 RDH11 HSD17B10 UQCRC2 CTPS1 FUBP3 DYNC1H1 | 3.06e-09 | 1425 | 109 | 21 | 30948266 |
| Pubmed | SmgGDS displays differential binding and exchange activity towards different Ras isoforms. | 3.17e-09 | 7 | 109 | 4 | 11948427 | |
| Pubmed | The SDR (short-chain dehydrogenase/reductase and related enzymes) nomenclature initiative. | 3.36e-09 | 73 | 109 | 7 | 19027726 | |
| Pubmed | GPD2 KRAS ABCC1 ABCB7 HK1 ETFA PFKM ECPAS SORT1 MS4A4A IGF2BP1 RDH11 AASS LRP4 HSH2D HSD17B10 UQCRC2 EXOC2 CTPS1 FUBP3 DYNC1H1 | 3.67e-09 | 1440 | 109 | 21 | 30833792 | |
| Pubmed | 6.33e-09 | 8 | 109 | 4 | 15802388 | ||
| Pubmed | 6.96e-09 | 22 | 109 | 5 | 8894702 | ||
| Pubmed | 1.14e-08 | 9 | 109 | 4 | 24586238 | ||
| Pubmed | GPD2 ABCC1 ABCC4 ABCB7 ETFA TIMM23 ECPAS CBS NDUFV1 NUBP2 PRMT6 HSD17B10 UQCRC2 CTPS1 GMPPA DYNC1H1 | 1.59e-08 | 878 | 109 | 16 | 37223481 | |
| Pubmed | GPD2 ABCB7 HK1 MAOA ETFA TIMM23 OAS2 RTN4IP1 TMEM14DP NDUFV1 AASS TMEM14B HSD17B10 | 1.66e-08 | 542 | 109 | 13 | 14651853 | |
| Pubmed | GPD2 ABCB7 HK1 PFKM ECPAS BCS1L NDUFV1 SORT1 HSD17B10 UQCRC2 EXOC2 CTPS1 DYNC1H1 | 2.43e-08 | 560 | 109 | 13 | 35241646 | |
| Pubmed | 2.96e-08 | 11 | 109 | 4 | 11786539 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 16156793 | ||
| Pubmed | Diagnostic Value of RAS Mutations in Indeterminate Thyroid Nodules. | 2.99e-08 | 3 | 109 | 3 | 28116986 | |
| Pubmed | RAS gene mutations and histomorphometric measurements in oral squamous cell carcinoma. | 2.99e-08 | 3 | 109 | 3 | 37013448 | |
| Pubmed | Mutations of RAS gene family in specimens of bladder cancer. | 2.99e-08 | 3 | 109 | 3 | 19101897 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 25977330 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 33620658 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 22589270 | ||
| Pubmed | A requirement for wild-type Ras isoforms in mutant KRas-driven signalling and transformation. | 2.99e-08 | 3 | 109 | 3 | 23496764 | |
| Pubmed | Distribution of p21ras during primary palate formation of non-cleft and cleft strains of mice. | 2.99e-08 | 3 | 109 | 3 | 7776260 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 28630043 | ||
| Pubmed | Overexpression of wild-type p21Ras plays a prominent role in colorectal cancer. | 2.99e-08 | 3 | 109 | 3 | 28259994 | |
| Pubmed | The variable phenotype and low-risk nature of RAS-positive thyroid nodules. | 2.99e-08 | 3 | 109 | 3 | 26253102 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 16573741 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 25788415 | ||
| Pubmed | Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. | 2.99e-08 | 3 | 109 | 3 | 20090846 | |
| Pubmed | Comparison of liver oncogenic potential among human RAS isoforms. | 2.99e-08 | 3 | 109 | 3 | 26799184 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 21737741 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 31906952 | ||
| Pubmed | Partial functional overlap of the three ras genes in mouse embryonic development. | 2.99e-08 | 3 | 109 | 3 | 18059342 | |
| Pubmed | Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series. | 2.99e-08 | 3 | 109 | 3 | 23240926 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 17943694 | ||
| Pubmed | Absolute Quantification of Endogenous Ras Isoform Abundance. | 2.99e-08 | 3 | 109 | 3 | 26560143 | |
| Pubmed | Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. | 2.99e-08 | 3 | 109 | 3 | 17712732 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 24222113 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 28202657 | ||
| Pubmed | Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma. | 2.99e-08 | 3 | 109 | 3 | 16761621 | |
| Pubmed | Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis. | 2.99e-08 | 3 | 109 | 3 | 22945650 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 3045729 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 19303097 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 27911734 | ||
| Pubmed | Absence of oncogenic mutations of RAS family genes in soft tissue sarcomas of 100 Japanese patients. | 2.99e-08 | 3 | 109 | 3 | 20150643 | |
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 20971740 | ||
| Pubmed | 2.99e-08 | 3 | 109 | 3 | 27119512 | ||
| Pubmed | K-ras is an essential gene in the mouse with partial functional overlap with N-ras. | 2.99e-08 | 3 | 109 | 3 | 9334313 | |
| Pubmed | RGS14 is a novel Rap effector that preferentially regulates the GTPase activity of galphao. | 4.43e-08 | 12 | 109 | 4 | 10926822 | |
| Pubmed | 8.92e-08 | 14 | 109 | 4 | 9373155 | ||
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | KRAS RAP1A RAP1B NRAS ETFA PFKM PGK1 NDUFV1 HSD17B10 UQCRC2 DYNC1H1 | 9.75e-08 | 422 | 109 | 11 | 27342126 |
| Pubmed | HK1 ETFA RTN4IP1 PFKM BCS1L NDUFV1 ABCB8 HSD17B10 UQCRC2 DYNC1H1 | 9.87e-08 | 331 | 109 | 10 | 29199018 | |
| Pubmed | The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. | 1.20e-07 | 4 | 109 | 3 | 27936046 | |
| Pubmed | Reducing Pericyte-Derived Scarring Promotes Recovery after Spinal Cord Injury. | 1.20e-07 | 4 | 109 | 3 | 29502968 | |
| Pubmed | Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. | 1.20e-07 | 4 | 109 | 3 | 7972015 | |
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 10490827 | ||
| Pubmed | Tyrosine phosphorylation of RAS by ABL allosterically enhances effector binding. | 1.20e-07 | 4 | 109 | 3 | 25999467 | |
| Pubmed | Identification and characterization of potential effector molecules of the Ras-related GTPase Rap2. | 1.20e-07 | 4 | 109 | 3 | 10085114 | |
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 10085069 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 38849523 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 34948093 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 9674433 | ||
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 18690847 | ||
| Pubmed | Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon. | 1.20e-07 | 4 | 109 | 3 | 12444546 | |
| Pubmed | Ras membrane orientation and nanodomain localization generate isoform diversity. | 1.20e-07 | 4 | 109 | 3 | 20080631 | |
| Pubmed | cGMP transport by vesicles from human and mouse erythrocytes. | 1.20e-07 | 4 | 109 | 3 | 17229149 | |
| Pubmed | Quantification of spatiotemporal patterns of Ras isoform expression during development. | 1.20e-07 | 4 | 109 | 3 | 28117393 | |
| Pubmed | 1.20e-07 | 4 | 109 | 3 | 30049443 | ||
| Pubmed | Human skeletal muscle drug transporters determine local exposure and toxicity of statins. | 1.20e-07 | 4 | 109 | 3 | 19940267 | |
| Pubmed | 1.21e-07 | 15 | 109 | 4 | 28112518 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | GPD2 ABCB7 HK1 MAOA RBM33 VPS13C PCLO ETFA TIMM23 RTN4IP1 PFKM BCS1L NDUFV1 NUBP2 IGF2BP1 AASS HSD17B10 UQCRC2 FUBP3 | 1.95e-07 | 1496 | 109 | 19 | 32877691 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | GPD2 KRAS HK1 NRAS PCLO ETFA MUC19 OLA1 ECPAS PGK1 MTAP HSD17B10 ATP2A1 DYNC1H1 | 2.46e-07 | 807 | 109 | 14 | 30575818 |
| Pubmed | 2.70e-07 | 18 | 109 | 4 | 9069267 | ||
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 22982107 | ||
| Pubmed | Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions. | 2.98e-07 | 5 | 109 | 3 | 34535655 | |
| Pubmed | Ubiquitylation by Rab40b/Cul5 regulates Rap2 localization and activity during cell migration. | 2.98e-07 | 5 | 109 | 3 | 35293963 | |
| Pubmed | Identification of a specific effector of the small GTP-binding protein Rap2. | 2.98e-07 | 5 | 109 | 3 | 9523700 | |
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 25533468 | ||
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 9069260 | ||
| Pubmed | Impeded Nedd4-1-mediated Ras degradation underlies Ras-driven tumorigenesis. | 2.98e-07 | 5 | 109 | 3 | 24746824 | |
| Pubmed | Activated Ras induces lens epithelial cell hyperplasia but not premature differentiation. | 2.98e-07 | 5 | 109 | 3 | 15558479 | |
| Pubmed | 2.98e-07 | 5 | 109 | 3 | 9266971 | ||
| Pubmed | Efflux protein expression in human stem cell-derived retinal pigment epithelial cells. | 2.98e-07 | 5 | 109 | 3 | 22272278 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RAP1B HK1 POLR1A CBS NUBP2 IGF2BP1 CTPS2 RDH11 UQCRC2 CTPS1 GMPPA FUBP3 DYNC1H1 | 3.38e-07 | 704 | 109 | 13 | 29955894 |
| Pubmed | ABCC1 RAP1A ABCB7 RAP2B HK1 IGF2BP1 SLC5A6 HSD17B10 UQCRC2 FUBP3 DYNC1H1 | 3.81e-07 | 484 | 109 | 11 | 31995728 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | GPD2 TIMM23 OLA1 PFKM CBS PGK1 NUBP2 IGF2BP1 CTPS2 MTAP SLC4A1AP DECR2 IRS2 HSD17B10 UQCRC2 EXOC2 CTPS1 DYNC1H1 | 4.16e-07 | 1415 | 109 | 18 | 28515276 |
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 21072204 | ||
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 10882715 | ||
| Pubmed | Glutamate transporter Slc1a3 mediates inter-niche stem cell activation during skin growth. | 5.95e-07 | 6 | 109 | 3 | 29615452 | |
| Pubmed | LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases. | 5.95e-07 | 6 | 109 | 3 | 31337872 | |
| Pubmed | 5.95e-07 | 6 | 109 | 3 | 12581858 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | GPD2 ABCC1 RAP1A ABCB7 MAOA RBM33 ETFA OAS2 PFKM BCS1L NDUFV1 MTAP RDH11 SLC4A1AP UQCRC2 CTPS1 HSD17B11 DNAH6 | 5.99e-07 | 1451 | 109 | 18 | 30550785 |
| Pubmed | KRAS ABCC1 ABCC4 NRAS DHRS13 OAS2 OLA1 ECPAS PGK1 INTS2 NBEAL2 EXOC2 CTPS1 KDSR FUBP3 DYNC1H1 | 7.52e-07 | 1168 | 109 | 16 | 19946888 | |
| Interaction | RGL1 interactions | 3.26e-08 | 18 | 108 | 5 | int:RGL1 | |
| Interaction | RALGDS interactions | 3.52e-08 | 36 | 108 | 6 | int:RALGDS | |
| Interaction | RAP1GDS1 interactions | 6.76e-08 | 141 | 108 | 9 | int:RAP1GDS1 | |
| Interaction | RASSF5 interactions | 3.43e-07 | 52 | 108 | 6 | int:RASSF5 | |
| Interaction | C9orf72 interactions | KRAS RAP1A RAP1B ABCB7 HK1 NRAS POLR1A ETFA TIMM23 PFKM CBS NUBP2 IGF2BP1 CTPS2 AASS HRAS HSD17B10 UQCRC2 CTPS1 HSD17B11 GMPPA FUBP3 DYNC1H1 | 4.03e-07 | 1319 | 108 | 23 | int:C9orf72 |
| Interaction | RAB23 interactions | 4.31e-07 | 54 | 108 | 6 | int:RAB23 | |
| Interaction | BSG interactions | KRAS ABCC1 RAP1A NRAS CFTR ECPAS RDH11 NBEAL2 TMEM14B HRAS DECR2 HSD17B10 EXOC2 ATP2A1 FUBP3 | 1.37e-06 | 631 | 108 | 15 | int:BSG |
| Interaction | GYPC interactions | 2.84e-06 | 19 | 108 | 4 | int:GYPC | |
| Interaction | HEPH interactions | 2.96e-06 | 6 | 108 | 3 | int:HEPH | |
| Interaction | LGALS9 interactions | ABCC1 ABCC4 RAP1A ABCB7 RAP2B HK1 CFTR ABCC5 IGF2BP1 SLC5A6 HSD17B10 UQCRC2 FUBP3 DYNC1H1 | 3.12e-06 | 588 | 108 | 14 | int:LGALS9 |
| Interaction | COQ9 interactions | 5.45e-06 | 238 | 108 | 9 | int:COQ9 | |
| Interaction | FAF2 interactions | GPD2 KRAS ABCB7 NRAS VPS13C CFTR TIMM23 TRIM23 SORT1 UQCRC2 HSD17B11 ATP2A1 | 5.46e-06 | 451 | 108 | 12 | int:FAF2 |
| Interaction | C9orf78 interactions | GPD2 ABCB7 HK1 PFKM ECPAS BCS1L NDUFV1 NUBP2 SORT1 HSD17B10 UQCRC2 EXOC2 CTPS1 DYNC1H1 | 5.73e-06 | 620 | 108 | 14 | int:C9orf78 |
| Interaction | SERBP1 interactions | GPD2 ABCC1 ABCC4 ABCB7 NRAS PCLO ETFA TIMM23 ECPAS CBS NDUFV1 NUBP2 PRMT6 IGF2BP1 CTPS2 RDH11 HSD17B10 UQCRC2 CTPS1 GMPPA FUBP3 DYNC1H1 | 6.02e-06 | 1432 | 108 | 22 | int:SERBP1 |
| Interaction | CDC42 interactions | A2M KRAS ABCC1 RAP1A RAP1B ABCB7 RAP2B NEK6 CFTR ETFA ABCC5 OLA1 PFKM ECPAS NDUFV1 IGF2BP1 INTS2 AASS HRAS HSD17B10 UQCRC2 | 6.18e-06 | 1323 | 108 | 21 | int:CDC42 |
| Interaction | CLDN1 interactions | 1.06e-05 | 26 | 108 | 4 | int:CLDN1 | |
| Interaction | RAP2C interactions | 1.13e-05 | 55 | 108 | 5 | int:RAP2C | |
| Interaction | RGL2 interactions | 1.45e-05 | 28 | 108 | 4 | int:RGL2 | |
| Interaction | TRPV2 interactions | 1.75e-05 | 10 | 108 | 3 | int:TRPV2 | |
| Interaction | SPRTN interactions | RAP2B NEK6 ETFA TIMM23 PFKM CTPS2 UQCRC2 CTPS1 RAP2C HSD17B11 GMPPA ATP2A1 DYNC1H1 | 1.83e-05 | 596 | 108 | 13 | int:SPRTN |
| Interaction | RHOA interactions | KRAS ABCC1 RAP1B ABCB7 RAP2B HK1 VPS13C CFTR ETFA ABCC5 NDUFV1 NUBP2 RDH11 HSD17B10 UQCRC2 PATJ RAP2C FUBP3 PLXNB1 | 1.88e-05 | 1199 | 108 | 19 | int:RHOA |
| Interaction | ANO10 interactions | 2.20e-05 | 31 | 108 | 4 | int:ANO10 | |
| Interaction | ARFGAP3 interactions | 2.67e-05 | 109 | 108 | 6 | int:ARFGAP3 | |
| Interaction | PDZK1 interactions | 2.77e-05 | 66 | 108 | 5 | int:PDZK1 | |
| Interaction | PDE6D interactions | 2.77e-05 | 66 | 108 | 5 | int:PDE6D | |
| Interaction | CMTM8 interactions | 2.99e-05 | 67 | 108 | 5 | int:CMTM8 | |
| Interaction | GTSF1 interactions | 3.18e-05 | 12 | 108 | 3 | int:GTSF1 | |
| Interaction | GPR45 interactions | 3.43e-05 | 300 | 108 | 9 | int:GPR45 | |
| Interaction | UBIAD1 interactions | 3.44e-05 | 114 | 108 | 6 | int:UBIAD1 | |
| Interaction | USP32 interactions | 3.44e-05 | 114 | 108 | 6 | int:USP32 | |
| Interaction | LRPPRC interactions | KRAS ABCB7 HK1 POLR1A NEK6 CFTR ETFA RTN4IP1 BCS1L NDUFV1 IGF2BP1 SLC4A1AP AASS HSD17B10 UQCRC2 | 3.47e-05 | 827 | 108 | 15 | int:LRPPRC |
| Interaction | LRRC57 interactions | 3.59e-05 | 35 | 108 | 4 | int:LRRC57 | |
| Interaction | RAB1A interactions | KRAS RAP1A NRAS VPS13C ETFA IGF2BP1 MTAP HRAS UQCRC2 RAP2C KDSR | 3.97e-05 | 464 | 108 | 11 | int:RAB1A |
| Interaction | RASGRP2 interactions | 4.12e-05 | 13 | 108 | 3 | int:RASGRP2 | |
| Interaction | LINC02870 interactions | 4.12e-05 | 13 | 108 | 3 | int:LINC02870 | |
| Interaction | PAK6 interactions | 4.53e-05 | 73 | 108 | 5 | int:PAK6 | |
| Interaction | SHOC2 interactions | 4.83e-05 | 74 | 108 | 5 | int:SHOC2 | |
| Interaction | ITGB6 interactions | 5.22e-05 | 14 | 108 | 3 | int:ITGB6 | |
| Interaction | PLD3 interactions | 5.42e-05 | 246 | 108 | 8 | int:PLD3 | |
| Interaction | RAPGEF1 interactions | 5.55e-05 | 39 | 108 | 4 | int:RAPGEF1 | |
| Interaction | RAPGEF6 interactions | 6.23e-05 | 78 | 108 | 5 | int:RAPGEF6 | |
| Interaction | UBXN8 interactions | 7.03e-05 | 80 | 108 | 5 | int:UBXN8 | |
| Interaction | SLC33A1 interactions | 7.17e-05 | 189 | 108 | 7 | int:SLC33A1 | |
| Interaction | SLC4A8 interactions | 7.46e-05 | 42 | 108 | 4 | int:SLC4A8 | |
| Interaction | DHODH interactions | 7.46e-05 | 81 | 108 | 5 | int:DHODH | |
| Interaction | KDF1 interactions | 7.91e-05 | 192 | 108 | 7 | int:KDF1 | |
| Interaction | ELMOD3 interactions | 7.97e-05 | 16 | 108 | 3 | int:ELMOD3 | |
| Interaction | SAMSN1 interactions | 7.97e-05 | 16 | 108 | 3 | int:SAMSN1 | |
| Interaction | SFT2D1 interactions | 8.19e-05 | 43 | 108 | 4 | int:SFT2D1 | |
| Interaction | MCU interactions | 9.00e-05 | 196 | 108 | 7 | int:MCU | |
| Interaction | EI24 interactions | 9.93e-05 | 86 | 108 | 5 | int:EI24 | |
| Interaction | ALDOC interactions | 1.08e-04 | 140 | 108 | 6 | int:ALDOC | |
| Interaction | PLSCR3 interactions | 1.27e-04 | 48 | 108 | 4 | int:PLSCR3 | |
| Interaction | MT-CYB interactions | 1.36e-04 | 19 | 108 | 3 | int:MT-CYB | |
| Interaction | SHISA2 interactions | 1.36e-04 | 19 | 108 | 3 | int:SHISA2 | |
| Interaction | RAPGEF4 interactions | 1.49e-04 | 50 | 108 | 4 | int:RAPGEF4 | |
| Interaction | RP2 interactions | 1.59e-04 | 95 | 108 | 5 | int:RP2 | |
| Interaction | SLC6A9 interactions | 1.60e-04 | 20 | 108 | 3 | int:SLC6A9 | |
| Interaction | SUSD5 interactions | 1.60e-04 | 20 | 108 | 3 | int:SUSD5 | |
| Interaction | OR2T10 interactions | 1.70e-04 | 4 | 108 | 2 | int:OR2T10 | |
| Interaction | PDHA1 interactions | ABCB7 CFTR ETFA RTN4IP1 PFKM BCS1L NDUFV1 AASS HSD17B10 UQCRC2 ATP2A1 FUBP3 DYNC1H1 | 1.88e-04 | 750 | 108 | 13 | int:PDHA1 |
| Interaction | POR interactions | 1.95e-04 | 222 | 108 | 7 | int:POR | |
| Interaction | HMOX2 interactions | 1.99e-04 | 297 | 108 | 8 | int:HMOX2 | |
| Interaction | SELENOS interactions | 2.01e-04 | 54 | 108 | 4 | int:SELENOS | |
| Interaction | MDH2 interactions | KRAS ABCB7 HK1 CFTR ETFA RTN4IP1 BCS1L NDUFV1 AASS HSD17B10 UQCRC2 | 2.06e-04 | 559 | 108 | 11 | int:MDH2 |
| Interaction | RASIP1 interactions | 2.14e-04 | 22 | 108 | 3 | int:RASIP1 | |
| Interaction | NECTIN1 interactions | 2.14e-04 | 22 | 108 | 3 | int:NECTIN1 | |
| Interaction | ATL1 interactions | 2.31e-04 | 56 | 108 | 4 | int:ATL1 | |
| Interaction | FLOT1 interactions | 2.37e-04 | 475 | 108 | 10 | int:FLOT1 | |
| Interaction | SLC23A2 interactions | 2.45e-04 | 23 | 108 | 3 | int:SLC23A2 | |
| Interaction | SEMA4C interactions | 2.47e-04 | 163 | 108 | 6 | int:SEMA4C | |
| Interaction | BIRC3 interactions | GPD2 RAP1B HK1 POLR1A DNAH10 ETFA OLA1 PFKM CBS PGK1 NDUFV1 IGF2BP1 RDH11 HSD17B10 UQCRC2 CTPS1 FUBP3 DYNC1H1 | 2.48e-04 | 1334 | 108 | 18 | int:BIRC3 |
| Interaction | SLC18A2 interactions | 2.54e-04 | 105 | 108 | 5 | int:SLC18A2 | |
| Interaction | RHBDD2 interactions | 2.54e-04 | 105 | 108 | 5 | int:RHBDD2 | |
| Interaction | HK1 interactions | 2.68e-04 | 234 | 108 | 7 | int:HK1 | |
| Interaction | OR5M8 interactions | 2.82e-04 | 5 | 108 | 2 | int:OR5M8 | |
| Interaction | SLITRK2 interactions | 2.82e-04 | 5 | 108 | 2 | int:SLITRK2 | |
| Interaction | RABGGTB interactions | 2.90e-04 | 108 | 108 | 5 | int:RABGGTB | |
| Interaction | C8orf82 interactions | 2.91e-04 | 168 | 108 | 6 | int:C8orf82 | |
| Interaction | TRIM28 interactions | KRAS RAP1B HK1 NRAS POLR1A CFTR RSF1 CBS TRIM23 NUBP2 IGF2BP1 CTPS2 RDH11 HSD17B10 UQCRC2 CTPS1 GMPPA FUBP3 DYNC1H1 | 2.92e-04 | 1474 | 108 | 19 | int:TRIM28 |
| Interaction | MARVELD2 interactions | 3.02e-04 | 60 | 108 | 4 | int:MARVELD2 | |
| Interaction | F11R interactions | 3.02e-04 | 60 | 108 | 4 | int:F11R | |
| Interaction | CS interactions | GPD2 ABCB7 ETFA RTN4IP1 BCS1L NDUFV1 AASS HSD17B10 UQCRC2 CTPS1 | 3.04e-04 | 490 | 108 | 10 | int:CS |
| Interaction | COMT interactions | 3.20e-04 | 171 | 108 | 6 | int:COMT | |
| Interaction | MTMR1 interactions | 3.29e-04 | 111 | 108 | 5 | int:MTMR1 | |
| Interaction | ALDOA interactions | 3.36e-04 | 321 | 108 | 8 | int:ALDOA | |
| Interaction | SLC5A3 interactions | 3.43e-04 | 62 | 108 | 4 | int:SLC5A3 | |
| Interaction | C2CD2L interactions | 3.43e-04 | 112 | 108 | 5 | int:C2CD2L | |
| Interaction | RIN1 interactions | 3.57e-04 | 113 | 108 | 5 | int:RIN1 | |
| Interaction | CANX interactions | KRAS ABCC1 DNAH3 DNAH10 CFTR ETFA PGK1 NDUFV1 SORT1 LIPC SLC5A6 UQCRC2 HSD17B11 KDSR ATP2A1 DNAH9 PLXNB1 | 3.79e-04 | 1261 | 108 | 17 | int:CANX |
| Interaction | CALR interactions | 3.89e-04 | 414 | 108 | 9 | int:CALR | |
| Interaction | GBA2 interactions | 3.99e-04 | 27 | 108 | 3 | int:GBA2 | |
| Interaction | PDLIM4 interactions | 3.99e-04 | 27 | 108 | 3 | int:PDLIM4 | |
| Interaction | CABCOCO1 interactions | 3.99e-04 | 27 | 108 | 3 | int:CABCOCO1 | |
| Interaction | ABCC11 interactions | 4.21e-04 | 6 | 108 | 2 | int:ABCC11 | |
| Interaction | CGB8 interactions | 4.21e-04 | 6 | 108 | 2 | int:CGB8 | |
| Interaction | SLC9A1 interactions | 4.36e-04 | 118 | 108 | 5 | int:SLC9A1 | |
| Interaction | AARS2 interactions | 4.38e-04 | 334 | 108 | 8 | int:AARS2 | |
| Interaction | NHERF2 interactions | 4.59e-04 | 183 | 108 | 6 | int:NHERF2 | |
| Interaction | AGR2 interactions | GPD2 KRAS HK1 NRAS PCLO ETFA MUC19 OLA1 ECPAS PGK1 MTAP HSD17B10 ATP2A1 DYNC1H1 | 4.63e-04 | 934 | 108 | 14 | int:AGR2 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 5.81e-04 | 159 | 109 | 4 | chr7q36 | |
| Cytoband | 1p13.3 | 6.09e-04 | 69 | 109 | 3 | 1p13.3 | |
| Cytoband | Xq13.3 | 1.03e-03 | 20 | 109 | 2 | Xq13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 1.66e-03 | 211 | 109 | 4 | chr1p13 | |
| Cytoband | 10q25.3 | 2.17e-03 | 29 | 109 | 2 | 10q25.3 | |
| GeneFamily | RAS type GTPase family | 5.43e-13 | 31 | 77 | 8 | 389 | |
| GeneFamily | ATP binding cassette subfamily C | 8.20e-12 | 13 | 77 | 6 | 807 | |
| GeneFamily | Short chain dehydrogenase/reductase superfamily | 3.32e-08 | 76 | 77 | 7 | 743 | |
| GeneFamily | Dyneins, axonemal | 6.94e-07 | 17 | 77 | 4 | 536 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 6.32e-04 | 9 | 77 | 2 | 1223 | |
| GeneFamily | ATP binding cassette subfamily B | 9.60e-04 | 11 | 77 | 2 | 806 | |
| GeneFamily | Lipases|Arylacetamide deacetylase family | 3.91e-03 | 22 | 77 | 2 | 464 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.09e-07 | 156 | 108 | 7 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-07 | 184 | 108 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.61e-07 | 186 | 108 | 7 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 1.87e-06 | 151 | 108 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 160 | 108 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-06 | 160 | 108 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 6.02e-06 | 185 | 108 | 6 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.60e-06 | 188 | 108 | 6 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 7.01e-06 | 190 | 108 | 6 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.14e-06 | 195 | 108 | 6 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 8.14e-06 | 195 | 108 | 6 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 8.38e-06 | 196 | 108 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.40e-06 | 200 | 108 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-05 | 154 | 108 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.69e-05 | 154 | 108 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-05 | 167 | 108 | 5 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.75e-05 | 169 | 108 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 169 | 108 | 5 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 5.91e-05 | 170 | 108 | 5 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 172 | 108 | 5 | feaaf8ca7983d04a59ed0a7b3fb0e6d4b3a055f2 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 172 | 108 | 5 | 9adfb4a65669cc536343616637058d0a4728013f | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-05 | 172 | 108 | 5 | 8aed9c113f27d00401c272a3684495a4bc75bd0f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 6.96e-05 | 176 | 108 | 5 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.54e-05 | 179 | 108 | 5 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.95e-05 | 181 | 108 | 5 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | P07-Epithelial-airway_epithelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.59e-05 | 184 | 108 | 5 | a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-club_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.59e-05 | 184 | 108 | 5 | ab469b9e06212462cbe2e4db8775c6778db855e6 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 8.59e-05 | 184 | 108 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.04e-05 | 186 | 108 | 5 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 9.04e-05 | 186 | 108 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 9.27e-05 | 187 | 108 | 5 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 187 | 108 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 187 | 108 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.27e-05 | 187 | 108 | 5 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated-Ciliated_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.74e-05 | 189 | 108 | 5 | 057d7a03fdbe779122b203619a6f947f49b84d28 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-05 | 189 | 108 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.74e-05 | 189 | 108 | 5 | 9f57a131902d23494bf389baf6e6e2d99f88b2c8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.74e-05 | 189 | 108 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.74e-05 | 189 | 108 | 5 | e443b02502edaefa94567a9e8af5756e8e11ff30 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | 356C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.99e-05 | 190 | 108 | 5 | d541e076137cf7334bdb0ed69db2f9a27c668c65 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.99e-05 | 190 | 108 | 5 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 191 | 108 | 5 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-04 | 191 | 108 | 5 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 191 | 108 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | (12)_SLC16A7+|World / shred by cell type by condition | 1.02e-04 | 191 | 108 | 5 | e427eeddd2e87c14376a37db0b43f120c90436bc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 192 | 108 | 5 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 192 | 108 | 5 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.05e-04 | 192 | 108 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.05e-04 | 192 | 108 | 5 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Monocytes-Tissue-resident_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.07e-04 | 193 | 108 | 5 | 198552810dcac8d0ca63a78badd6702b49ff6edf | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.07e-04 | 193 | 108 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.07e-04 | 193 | 108 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | Monocytes-Phagocytic_CD16+_macrophages|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis | 1.10e-04 | 194 | 108 | 5 | 40dbfdf1d7e6b73d120d8f802f08e573fe9a739e | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-04 | 195 | 108 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.13e-04 | 195 | 108 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.13e-04 | 195 | 108 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.13e-04 | 195 | 108 | 5 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 108 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 1.13e-04 | 195 | 108 | 5 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 108 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.16e-04 | 196 | 108 | 5 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 197 | 108 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / Treatment groups by lineage, cell group, cell type | 1.18e-04 | 197 | 108 | 5 | 1a1bee8da6e04b65935c40373eaee4d6c046d9a1 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.18e-04 | 197 | 108 | 5 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.21e-04 | 198 | 108 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-04 | 198 | 108 | 5 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.24e-04 | 199 | 108 | 5 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.24e-04 | 199 | 108 | 5 | 63e632b06e13d2bcde5a00a51962bafdf60fd6c6 | |
| ToppCell | Sepsis-URO|Sepsis / Disease, condition lineage and cell class | 1.24e-04 | 199 | 108 | 5 | 8e6dac82d1d0e759cd567f9c95b70cb4801d7caf | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 1.24e-04 | 199 | 108 | 5 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 1.24e-04 | 199 | 108 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.27e-04 | 200 | 108 | 5 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.27e-04 | 200 | 108 | 5 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-04 | 200 | 108 | 5 | 4f481d87e30195365900acb5d50641a9e7b2f462 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.27e-04 | 200 | 108 | 5 | 5490393c5f54748f912676e19b58bd1320415a06 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.27e-04 | 200 | 108 | 5 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | COVID-19-Myeloid-MoAM2,_CCL18|COVID-19 / Condition, Lineage and Cell class | 1.27e-04 | 200 | 108 | 5 | b0a50622d00335843efad86bc56a1e910019984b | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.27e-04 | 200 | 108 | 5 | cf720d3973e79ffd4c6e763a7284799ced22a274 | |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.27e-04 | 200 | 108 | 5 | df821ac12953e44fcfedbbefb35a4976e406ccd6 | |
| ToppCell | LPS-IL1RA-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-04 | 127 | 108 | 4 | 6b24630978eb0772b4cd3bf59e5bc4390be47619 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.17e-04 | 144 | 108 | 4 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.62e-04 | 148 | 108 | 4 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.62e-04 | 148 | 108 | 4 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.86e-04 | 150 | 108 | 4 | ecc4fc94958cf2378dd003966dccba81b3c00f8e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.98e-04 | 151 | 108 | 4 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-04 | 154 | 108 | 4 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-04 | 154 | 108 | 4 | 89a94a36dfd3d75e411038f04adaf0bbab17db45 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-04 | 154 | 108 | 4 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-04 | 155 | 108 | 4 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.50e-04 | 155 | 108 | 4 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.50e-04 | 155 | 108 | 4 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 5.63e-04 | 156 | 108 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.77e-04 | 157 | 108 | 4 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-04 | 158 | 108 | 4 | 0559cc032d0b518bb9e55aa3495f5573bd8e87dd | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_4|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.91e-04 | 158 | 108 | 4 | f9cfb110342be3c91aba9914805332f22ba89101 | |
| Computational | Small monomeric GTPases. | 5.48e-07 | 43 | 77 | 6 | MODULE_86 | |
| Computational | Genes in the cancer module 87. | 1.44e-05 | 44 | 77 | 5 | MODULE_87 | |
| Drug | Texas Red | 2.06e-07 | 28 | 109 | 5 | CID000452705 | |
| Drug | glutathione reduced | KRAS ABCC1 ABCC4 ABCB7 HK1 CFTR ABCC5 ABCC11 PFKM CBS NUBP2 AASS DYNC1H1 ABCC10 | 2.68e-07 | 534 | 109 | 14 | CID000000745 |
| Drug | L 744832 | 4.25e-07 | 4 | 109 | 3 | ctd:C096898 | |
| Drug | AC1L7GDJ | 4.25e-07 | 4 | 109 | 3 | CID000310029 | |
| Drug | adefovir | 6.27e-07 | 64 | 109 | 6 | CID000060172 | |
| Drug | beta-NADP | GPD2 CYP2A13 HK1 FMO5 PFKM PGK1 NDUFV1 RDH11 AASS DECR2 HSD17B10 HSD17B1 KDSR | 6.47e-07 | 490 | 109 | 13 | CID000000929 |
| Drug | PAK-104P | 6.51e-07 | 15 | 109 | 4 | CID000131368 | |
| Drug | AC1L4BIC | 8.65e-07 | 16 | 109 | 4 | CID000153998 | |
| Drug | Zidovudine | KRAS ABCC1 ABCC4 SLC26A3 SLC22A23 TIMM23 ABCC5 ABCC11 OAS2 NDUFV1 HRAS UQCRC2 ABCC10 | 1.28e-06 | 521 | 109 | 13 | ctd:D015215 |
| Drug | Apa-sg | 1.82e-06 | 19 | 109 | 4 | CID000126348 | |
| Drug | glycerol | GPD2 ABCB7 HK1 POLR1A MAOA CFTR ADGRV1 PFKM CBS PGK1 SORT1 LIPC HSD17B10 UQCRC2 HSD17B1 HSD17B11 | 2.08e-06 | 829 | 109 | 16 | CID000000753 |
| Drug | AC1LAHTK | 2.11e-06 | 6 | 109 | 3 | CID000468713 | |
| Drug | lactate | GPD2 HK1 ETFA ADGRV1 PFKM BCS1L PGK1 NDUFV1 AASS ABCB8 HSD17B10 UQCRC2 | 2.19e-06 | 461 | 109 | 12 | CID000000612 |
| Drug | O746 | 2.27e-06 | 20 | 109 | 4 | CID006327063 | |
| Drug | pralatrexate | 2.79e-06 | 21 | 109 | 4 | CID000148121 | |
| Drug | AC1L1IZE | 3.25e-06 | 131 | 109 | 7 | CID000004799 | |
| Drug | AC1Q5X3R | 3.40e-06 | 22 | 109 | 4 | CID000108075 | |
| Drug | VX-710 | 3.40e-06 | 22 | 109 | 4 | CID000406509 | |
| Drug | docetaxel | 3.60e-06 | 133 | 109 | 7 | ctd:C067311 | |
| Drug | t408 | 3.68e-06 | 7 | 109 | 3 | CID000005778 | |
| Drug | hydroxyrubicin | 4.10e-06 | 23 | 109 | 4 | CID000072398 | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; PC3; HT_HG-U133A | 4.73e-06 | 196 | 109 | 8 | 5871_UP | |
| Drug | melarsen oxide | 4.91e-06 | 24 | 109 | 4 | CID000030830 | |
| Drug | Glutathione | 5.57e-06 | 340 | 109 | 10 | ctd:D005978 | |
| Drug | PMEG | 5.82e-06 | 25 | 109 | 4 | CID000064989 | |
| Drug | AC1NE3ZR | 6.85e-06 | 26 | 109 | 4 | CID004636208 | |
| Drug | AC1Q5QTP | 8.01e-06 | 27 | 109 | 4 | CID000071324 | |
| Drug | AC1L32OA | 8.78e-06 | 9 | 109 | 3 | CID000107745 | |
| Drug | hydride | GPD2 CYP2A13 SLC26A3 FMO5 MAOA CFTR ETFA NDUFV1 AASS ABCB8 DECR2 HSD17B10 UQCRC2 KDSR ATP2A1 | 1.06e-05 | 835 | 109 | 15 | CID000000783 |
| Drug | fluorescein | 1.07e-05 | 157 | 109 | 7 | CID000016850 | |
| Drug | 1 mN-9 | 1.25e-05 | 10 | 109 | 3 | CID000122108 | |
| Drug | NADP | 1.28e-05 | 107 | 109 | 6 | ctd:D009249 | |
| Drug | glibenclamide | 1.53e-05 | 382 | 109 | 10 | CID000003488 | |
| Drug | 17beta-estradiol glucuronide | 1.61e-05 | 32 | 109 | 4 | CID000066424 | |
| Drug | heptamolybdate | 1.66e-05 | 112 | 109 | 6 | CID005288823 | |
| Drug | phenanthrene | 1.75e-05 | 113 | 109 | 6 | ctd:C031181 | |
| Drug | sodium glycocholate | 2.02e-05 | 69 | 109 | 5 | CID000000755 | |
| Drug | AC1L8YYB | 2.06e-05 | 34 | 109 | 4 | CID000435167 | |
| Drug | monochlorobimane | 2.06e-05 | 34 | 109 | 4 | CID000114886 | |
| Drug | CHEMBL83995 | 2.27e-05 | 2 | 109 | 2 | CID009571169 | |
| Drug | isoprene | 2.27e-05 | 2 | 109 | 2 | ctd:C005059 | |
| Drug | 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein | 2.27e-05 | 2 | 109 | 2 | ctd:C043829 | |
| Drug | heptylamine | 2.28e-05 | 12 | 109 | 3 | CID000008127 | |
| Drug | Fe4S4 | 2.68e-05 | 249 | 109 | 8 | CID000439317 | |
| Drug | benzbromarone | 2.91e-05 | 37 | 109 | 4 | CID000002333 | |
| Drug | harmol sulfate | 2.95e-05 | 13 | 109 | 3 | CID005488302 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 3.10e-05 | 125 | 109 | 6 | CID000002603 | |
| Drug | 3-isoreserpine | 3.67e-05 | 190 | 109 | 7 | CID000005052 | |
| Drug | CDCF | 3.74e-05 | 14 | 109 | 3 | CID000132525 | |
| Drug | tetramethylrosamine | 3.74e-05 | 14 | 109 | 3 | CID000443313 | |
| Drug | Epi Lovastatin | 3.91e-05 | 341 | 109 | 9 | CID000003962 | |
| Drug | reduced diphosphopyridine nucleotide | 4.00e-05 | 342 | 109 | 9 | CID000000928 | |
| Drug | beta-Naphthoflavone | A2M GPD2 ABCC1 ABCC4 CYP2A13 FMO5 RBM33 ABCC5 SORT1 RDH11 IRS2 CSMD1 DNAH9 DYNC1H1 | 4.14e-05 | 828 | 109 | 14 | ctd:D019324 |
| Drug | Biliton | 4.39e-05 | 41 | 109 | 4 | CID000002974 | |
| Drug | orthovanadate | 4.62e-05 | 435 | 109 | 10 | CID000061672 | |
| Drug | Pemetrexed | 4.84e-05 | 42 | 109 | 4 | ctd:D000068437 | |
| Drug | Pheniramine maleate [132-20-7]; Down 200; 11.2uM; PC3; HT_HG-U133A | 4.92e-05 | 199 | 109 | 7 | 4012_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 5.08e-05 | 200 | 109 | 7 | 4377_DN | |
| Drug | amsacrine | 6.37e-05 | 45 | 109 | 4 | CID000002179 | |
| Drug | hydroxyl radicals | GPD2 ABCC1 CYP2A13 RAP1B HK1 FMO5 MAOA PFKM CBS LIPC CTPS2 NUDT3 TRIM9 AASS HSD17B10 UQCRC2 CTPS1 ATP2A1 | 6.51e-05 | 1341 | 109 | 18 | CID000000961 |
| Drug | 1 sulfonylurea | 6.58e-05 | 143 | 109 | 6 | CID011819083 | |
| Drug | AC1L977H | 6.79e-05 | 3 | 109 | 2 | CID000439366 | |
| Drug | hmimBF4 | 6.79e-05 | 3 | 109 | 2 | CID002734179 | |
| Drug | GGTI 2147 | 6.79e-05 | 3 | 109 | 2 | ctd:C466792 | |
| Drug | S-(2,4-dinitrophenyl)glutathione | 6.79e-05 | 3 | 109 | 2 | ctd:C030190 | |
| Drug | Tetranitromethane | 6.79e-05 | 3 | 109 | 2 | ctd:D013774 | |
| Drug | 1-octyl-3-methylimidazolium tetrafluoroborate | 6.79e-05 | 3 | 109 | 2 | CID011460221 | |
| Drug | NSC95943 | 7.69e-05 | 91 | 109 | 5 | CID000003044 | |
| Drug | AC 93253 | 9.78e-05 | 19 | 109 | 3 | ctd:C542662 | |
| Drug | Adenosine Diphosphate | 1.04e-04 | 51 | 109 | 4 | ctd:D000244 | |
| Drug | B-Go | 1.15e-04 | 20 | 109 | 3 | CID000644262 | |
| Drug | agaric acid | 1.15e-04 | 20 | 109 | 3 | CID000012629 | |
| Drug | vanadyl | 1.17e-04 | 307 | 109 | 8 | CID000061671 | |
| Drug | verapamil | ABCC1 ABCC4 CYP2A13 ABCB7 CFTR ABCC5 ABCB8 ABCD4 ATP2A1 ABCC10 | 1.24e-04 | 490 | 109 | 10 | CID000002520 |
| Drug | glutarate | 1.26e-04 | 101 | 109 | 5 | CID000000743 | |
| Drug | MSD-1 | 1.33e-04 | 21 | 109 | 3 | CID009845018 | |
| Drug | 2-octanol | 1.33e-04 | 21 | 109 | 3 | CID000020083 | |
| Drug | Fluorodeoxyuridylate | 1.35e-04 | 4 | 109 | 2 | ctd:D005468 | |
| Drug | 8-azidoadenosine 5'-triphosphate | 1.35e-04 | 4 | 109 | 2 | ctd:C017040 | |
| Drug | grepafloxacin glucuronide | 1.35e-04 | 4 | 109 | 2 | CID000443296 | |
| Drug | coenzyme 1 | GPD2 HK1 MAOA PFKM NDUFV1 RDH11 AASS DECR2 HSD17B10 UQCRC2 HSD17B1 | 1.36e-04 | 596 | 109 | 11 | CID000000925 |
| Drug | sulfobromophthalein | 1.38e-04 | 103 | 109 | 5 | CID000005345 | |
| Drug | acetate | GPD2 DNAH3 HK1 CFTR PFKM CBS PGK1 DECR2 ATP2A1 DNAH9 DYNC1H1 | 1.42e-04 | 599 | 109 | 11 | CID000000175 |
| Drug | NSC638615 | 1.65e-04 | 107 | 109 | 5 | CID000097535 | |
| Drug | Turbuhaler | 1.73e-04 | 108 | 109 | 5 | CID000002462 | |
| Drug | trequinsin | 1.73e-04 | 58 | 109 | 4 | CID000005537 | |
| Drug | magnesium | KRAS ABCC1 DNAH3 RAP1B RAP2A HK1 DNAH10 CFTR ADGRV1 PFKM PGK1 TRIM23 HRAS EXOC2 ATP2A1 DNAH9 DYNC1H1 | 1.83e-04 | 1325 | 109 | 17 | CID000000888 |
| Drug | NSC 117356 | 1.84e-04 | 246 | 109 | 7 | CID000004112 | |
| Drug | Probenecid | 1.85e-04 | 59 | 109 | 4 | ctd:D011339 | |
| Drug | glutamate | GPD2 HK1 CFTR PFKM BCS1L CBS PGK1 NDUFV1 SORT1 CTPS2 AASS ABCB8 UQCRC2 CTPS1 | 2.02e-04 | 962 | 109 | 14 | CID000000611 |
| Drug | pyruvic acid | 2.04e-04 | 424 | 109 | 9 | CID000001060 | |
| Drug | 6-methylpurine-2'-deoxyriboside | 2.10e-04 | 61 | 109 | 4 | CID000097184 | |
| Drug | 2,2,5,7,8-pentamethyl-1-hydroxychroman | 2.14e-04 | 252 | 109 | 7 | ctd:C029141 | |
| Drug | Calcein AM | 2.24e-04 | 62 | 109 | 4 | CID000390986 | |
| Drug | mevalonolactone | 2.25e-04 | 5 | 109 | 2 | ctd:C015367 | |
| Drug | 3-chloromethylthiochromone-1,1-dioxide | 2.25e-04 | 5 | 109 | 2 | CID000100620 | |
| Drug | alpha-bromohydrin | 2.25e-04 | 5 | 109 | 2 | CID000020827 | |
| Drug | NSC671054 | 2.25e-04 | 5 | 109 | 2 | CID005357223 | |
| Drug | adenine N1-oxide | 2.25e-04 | 5 | 109 | 2 | CID000093557 | |
| Drug | 3 PS | 2.25e-04 | 5 | 109 | 2 | CID000007784 | |
| Disease | Verrucous epidermal nevus | 4.77e-08 | 3 | 108 | 3 | C0362030 | |
| Disease | Nevus Sebaceus of Jadassohn | 4.77e-08 | 3 | 108 | 3 | C4552097 | |
| Disease | Organoid Nevus Phakomatosis | 4.77e-08 | 3 | 108 | 3 | C0265329 | |
| Disease | Linear nevus sebaceous syndrome | 4.77e-08 | 3 | 108 | 3 | cv:C4552097 | |
| Disease | Nevus sebaceous | 4.77e-08 | 3 | 108 | 3 | C3854181 | |
| Disease | Inflammatory linear verrucous epidermal nevus | 4.77e-08 | 3 | 108 | 3 | C0473574 | |
| Disease | SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME | 4.77e-08 | 3 | 108 | 3 | 163200 | |
| Disease | linear nevus sebaceous syndrome (is_implicated_in) | 4.77e-08 | 3 | 108 | 3 | DOID:0111530 (is_implicated_in) | |
| Disease | Noonan syndrome 3 (implicated_via_orthology) | 4.77e-08 | 3 | 108 | 3 | DOID:0060581 (implicated_via_orthology) | |
| Disease | Linear Verrucous Epidermal Nevus | 4.77e-08 | 3 | 108 | 3 | C3179502 | |
| Disease | cervical cancer (implicated_via_orthology) | 4.77e-08 | 3 | 108 | 3 | DOID:4362 (implicated_via_orthology) | |
| Disease | NEVUS, EPIDERMAL (disorder) | 4.74e-07 | 5 | 108 | 3 | C0334082 | |
| Disease | Follicular thyroid carcinoma | 4.74e-07 | 5 | 108 | 3 | C0206682 | |
| Disease | Hemimegalencephaly | 9.46e-07 | 6 | 108 | 3 | C0431391 | |
| Disease | RASopathy (implicated_via_orthology) | 3.94e-06 | 9 | 108 | 3 | DOID:0080690 (implicated_via_orthology) | |
| Disease | Noonan Syndrome 1 | 7.70e-06 | 11 | 108 | 3 | C4551602 | |
| Disease | Turner Syndrome, Male | 7.70e-06 | 11 | 108 | 3 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 7.70e-06 | 11 | 108 | 3 | C1527404 | |
| Disease | kidney cancer (implicated_via_orthology) | 7.70e-06 | 11 | 108 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | heart disease (implicated_via_orthology) | 1.14e-05 | 38 | 108 | 4 | DOID:114 (implicated_via_orthology) | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 1.33e-05 | 2 | 108 | 2 | 614470 | |
| Disease | Autoimmune lymphoproliferative syndrome type 4 | 1.33e-05 | 2 | 108 | 2 | cv:C2674723 | |
| Disease | autoimmune lymphoproliferative syndrome type 4 (is_implicated_in) | 1.33e-05 | 2 | 108 | 2 | DOID:0110117 (is_implicated_in) | |
| Disease | MELANOCYTIC NEVUS SYNDROME, CONGENITAL | 1.33e-05 | 2 | 108 | 2 | 137550 | |
| Disease | Melanocytic nevus | 1.33e-05 | 2 | 108 | 2 | cv:C0027962 | |
| Disease | RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER | 1.33e-05 | 2 | 108 | 2 | C2674723 | |
| Disease | large congenital melanocytic nevus (is_implicated_in) | 1.33e-05 | 2 | 108 | 2 | DOID:0111359 (is_implicated_in) | |
| Disease | Large congenital melanocytic nevus | 1.33e-05 | 2 | 108 | 2 | cv:C1842036 | |
| Disease | Liver carcinoma | 1.77e-05 | 507 | 108 | 10 | C2239176 | |
| Disease | high grade glioma (implicated_via_orthology) | 2.06e-05 | 44 | 108 | 4 | DOID:3070 (implicated_via_orthology) | |
| Disease | RASopathy | 2.10e-05 | 15 | 108 | 3 | cv:C5555857 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | 2.15e-05 | 315 | 108 | 8 | EFO_0004574, EFO_0004612 | |
| Disease | Disease Exacerbation | 3.34e-05 | 165 | 108 | 6 | C0235874 | |
| Disease | GIANT PIGMENTED HAIRY NEVUS | 3.97e-05 | 3 | 108 | 2 | C1842036 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 4.43e-05 | 19 | 108 | 3 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 4.43e-05 | 19 | 108 | 3 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 4.43e-05 | 19 | 108 | 3 | C1275081 | |
| Disease | Costello syndrome (disorder) | 4.43e-05 | 19 | 108 | 3 | C0587248 | |
| Disease | leukemia (implicated_via_orthology) | 4.43e-05 | 19 | 108 | 3 | DOID:1240 (implicated_via_orthology) | |
| Disease | LEOPARD Syndrome | 6.98e-05 | 22 | 108 | 3 | C0175704 | |
| Disease | Colorectal Neoplasms | 7.40e-05 | 277 | 108 | 7 | C0009404 | |
| Disease | Kabuki make-up syndrome | 7.93e-05 | 4 | 108 | 2 | C0796004 | |
| Disease | NEVUS, EPIDERMAL | 7.93e-05 | 4 | 108 | 2 | 162900 | |
| Disease | Malignant neoplasm of penis | 7.93e-05 | 4 | 108 | 2 | C0153601 | |
| Disease | Penile Neoplasms | 7.93e-05 | 4 | 108 | 2 | C0030849 | |
| Disease | Nevus, Keratinocytic, Nonepidermolytic | 7.93e-05 | 4 | 108 | 2 | C4011754 | |
| Disease | BLADDER CANCER | 7.93e-05 | 4 | 108 | 2 | 109800 | |
| Disease | Epidermal nevus | 7.93e-05 | 4 | 108 | 2 | cv:C0334082 | |
| Disease | Malignant tumor of urinary bladder | 7.93e-05 | 4 | 108 | 2 | cv:C0005684 | |
| Disease | Thyroid cancer, nonmedullary, 2 | 7.93e-05 | 4 | 108 | 2 | cv:C4225426 | |
| Disease | Malignant tumor of cervix | 7.93e-05 | 4 | 108 | 2 | C0007847 | |
| Disease | epidermal nevus (is_implicated_in) | 7.93e-05 | 4 | 108 | 2 | DOID:0111162 (is_implicated_in) | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 7.93e-05 | 4 | 108 | 2 | 188470 | |
| Disease | Noonan Syndrome | 9.13e-05 | 24 | 108 | 3 | C0028326 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.14e-04 | 206 | 108 | 6 | C0152013 | |
| Disease | THYROID CANCER, NONMEDULLARY, 2 | 1.32e-04 | 5 | 108 | 2 | C4225426 | |
| Disease | Malignant neoplasm of thyroid | 1.32e-04 | 5 | 108 | 2 | C0007115 | |
| Disease | Cetuximab response | 1.32e-04 | 5 | 108 | 2 | cv:CN077967 | |
| Disease | Cervix carcinoma | 1.32e-04 | 5 | 108 | 2 | C0302592 | |
| Disease | Panitumumab response | 1.32e-04 | 5 | 108 | 2 | cv:CN077999 | |
| Disease | Klatskin's tumor (is_implicated_in) | 1.32e-04 | 5 | 108 | 2 | DOID:4927 (is_implicated_in) | |
| Disease | TYPE 2 DIABETES MELLITUS | 1.46e-04 | 28 | 108 | 3 | 125853 | |
| Disease | Type 2 diabetes mellitus | 1.46e-04 | 28 | 108 | 3 | cv:C0011860 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.55e-04 | 312 | 108 | 7 | EFO_0004612, EFO_0010351 | |
| Disease | Strabismus | 1.63e-04 | 29 | 108 | 3 | HP_0000486 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.63e-04 | 29 | 108 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.80e-04 | 30 | 108 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Pleocytosis | 1.97e-04 | 6 | 108 | 2 | C0151857 | |
| Disease | Autoimmune lymphoproliferative syndrome | 1.97e-04 | 6 | 108 | 2 | cv:CN301239 | |
| Disease | Carcinoma in situ of uterine cervix | 1.97e-04 | 6 | 108 | 2 | C0851140 | |
| Disease | seminoma (is_implicated_in) | 1.97e-04 | 6 | 108 | 2 | DOID:4440 (is_implicated_in) | |
| Disease | Leukocytosis | 1.97e-04 | 6 | 108 | 2 | C0023518 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.19e-04 | 32 | 108 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 2.40e-04 | 33 | 108 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 2.60e-04 | 702 | 108 | 10 | C0009402 | |
| Disease | Thyroid cancer, follicular | 2.75e-04 | 7 | 108 | 2 | C2931367 | |
| Disease | Papillary thyroid carcinoma | 2.86e-04 | 86 | 108 | 4 | C0238463 | |
| Disease | Thyroid Neoplasm | 3.38e-04 | 37 | 108 | 3 | C0040136 | |
| Disease | Alzheimer's disease biomarker measurement, brain volume measurement | 3.66e-04 | 8 | 108 | 2 | EFO_0006514, EFO_0006930 | |
| Disease | Liver Diseases, Parasitic | 4.70e-04 | 9 | 108 | 2 | C0023897 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 4.70e-04 | 9 | 108 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | Hepatocellular Adenoma | 4.70e-04 | 9 | 108 | 2 | C0206669 | |
| Disease | Noonan syndrome | 4.70e-04 | 9 | 108 | 2 | cv:C0028326 | |
| Disease | neurotic disorder | 5.28e-04 | 101 | 108 | 4 | EFO_0004257 | |
| Disease | Thyroid carcinoma | 5.66e-04 | 44 | 108 | 3 | C0549473 | |
| Disease | thyroid gland papillary carcinoma (is_implicated_in) | 5.86e-04 | 10 | 108 | 2 | DOID:3969 (is_implicated_in) | |
| Disease | Streptozotocin Diabetes | 6.79e-04 | 108 | 108 | 4 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 6.79e-04 | 108 | 108 | 4 | C0011853 | |
| Disease | Alloxan Diabetes | 6.79e-04 | 108 | 108 | 4 | C0002152 | |
| Disease | Neuroblastoma | 6.88e-04 | 47 | 108 | 3 | C0027819 | |
| Disease | entorhinal cortical volume, Alzheimer's disease biomarker measurement | 7.14e-04 | 11 | 108 | 2 | EFO_0005092, EFO_0006514 | |
| Disease | Drug-induced depressive state | 8.55e-04 | 12 | 108 | 2 | C0338715 | |
| Disease | Drug habituation | 8.59e-04 | 115 | 108 | 4 | C0013170 | |
| Disease | Drug abuse | 8.59e-04 | 115 | 108 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 8.59e-04 | 115 | 108 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 8.59e-04 | 115 | 108 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 8.59e-04 | 115 | 108 | 4 | C0013222 | |
| Disease | Drug Dependence | 8.59e-04 | 115 | 108 | 4 | C1510472 | |
| Disease | Substance Dependence | 8.59e-04 | 115 | 108 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 8.59e-04 | 115 | 108 | 4 | C0038586 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLLGRTGSGKSTLLS | 1241 | P13569 | |
| GGILNRTAGAVGSKV | 2441 | Q96PZ7 | |
| GLVGVGTALALARKG | 21 | Q9Y276 | |
| RTGLGRLGVSLSKGL | 6 | Q9UDR5 | |
| VTLTVVRSPGGKGTV | 4056 | Q8WXG9 | |
| LGDRVLVGGTKTGVV | 221 | Q9UDT6 | |
| LVGGTKTGVVRYVGE | 226 | Q9UDT6 | |
| LLNIATRITGGGKSG | 681 | Q8N2N9 | |
| GNTGTGKTSLLRVLG | 421 | O14678 | |
| RKSVTGEIVLITGAG | 31 | Q8NBQ5 | |
| AGKALGIVATTGVGT | 216 | O14983 | |
| AKGGIVRTGTHGLLV | 501 | P01023 | |
| AGVRHIILVLSGKGG | 11 | Q9Y5Y2 | |
| IILVLSGKGGVGKST | 16 | Q9Y5Y2 | |
| LVVVGAGGVGKSALT | 6 | P01112 | |
| LVVVGAGGVGKSALT | 6 | P01116 | |
| LVVVGAGGVGKSALT | 6 | P01111 | |
| LVVLGSGGVGKSALT | 6 | P62834 | |
| LVVLGSGGVGKSALT | 6 | P61224 | |
| ISSKVRVIKLSGGGG | 981 | Q96EV2 | |
| VVVLGSGGVGKSALT | 6 | P10114 | |
| VVVLGSGGVGKSALT | 6 | P61225 | |
| VVVLGSGGVGKSALT | 6 | Q9Y3L5 | |
| TTTAVKIGIIGGTGL | 6 | Q13126 | |
| RGIEAVGGKLSVTAT | 101 | P22695 | |
| IGRFGTSLKIGIVGL | 16 | Q9NTK5 | |
| LNIATRITGGGKSGT | 666 | Q5JPF3 | |
| VVVIGGGISGLSAAK | 16 | P21397 | |
| LGIVGRTGSGKSSLL | 1276 | Q5T3U5 | |
| LTGVFTKGRAGLVTP | 621 | Q460N3 | |
| GTVFLRVGGAVRKTG | 371 | Q17RR3 | |
| AVKGTILVGGGALAT | 6 | P43304 | |
| GRGRSKLKSGIGAVV | 906 | Q8NEZ4 | |
| ASAAGRVIGKGGKTV | 496 | Q9NZI8 | |
| RGGRKSVSVAISLEG | 286 | Q9BZ68 | |
| LIRSGVGLGTKGGCA | 1366 | Q5VYK3 | |
| VGLGTKGGCASVIVS | 1371 | Q5VYK3 | |
| LVVTGGGGLRRFKTI | 1656 | Q9Y6V0 | |
| GGTRLTLNGSKLLTG | 1176 | O43157 | |
| KGDIIVTTKSGGRGT | 71 | Q96KP1 | |
| AGVKGTLGRLVGIFE | 71 | O95989 | |
| GTIGSSAVVTGIKGL | 5111 | Q7Z5P9 | |
| TLGIGKAIAVLTSGG | 11 | P08237 | |
| ASKVGLVIGRGGETI | 171 | Q96I24 | |
| RHKLGGGSGESILVS | 106 | Q9H0H0 | |
| VGIVGRTGSGKSSLG | 1171 | Q96J66 | |
| LRDKVAFITGGGSGI | 26 | Q9NUI1 | |
| TATGVVKLGDLGLGR | 181 | Q9HC98 | |
| IGGTHKIGRITGLDA | 181 | P11150 | |
| SGLGRHLGVVTGVSV | 451 | O75023 | |
| SRVGAGLGGLLTDKV | 201 | Q2VPB7 | |
| KATSRGCITIIGGGD | 361 | P00558 | |
| TAGLIIGKGGATVKA | 141 | Q9UNW9 | |
| GVAIGGSYGRKTVLR | 56 | P29728 | |
| GSGKGAALITAVGVR | 896 | P19367 | |
| RSVKGLVAVITGGAS | 6 | Q99714 | |
| VRRSTVISGPGTGKG | 236 | Q96JZ2 | |
| LKKVVTGRGALGGTA | 101 | Q96MD2 | |
| TVIGDRGTTLSGGQK | 526 | O15439 | |
| KSQEKVGIVGRTGAG | 1066 | O15439 | |
| VGIVGRTGAGKSSLI | 1071 | O15439 | |
| RTRSLGGLISAVGVG | 1286 | Q9Y4H2 | |
| VGICGSVGSGKTSLI | 591 | O15440 | |
| EKIGIVGRTGSGKSS | 1221 | O15440 | |
| SIGKGVTVGEGVRLR | 306 | Q96IJ6 | |
| GITGVGKSVIAKGLL | 2096 | Q9C0G6 | |
| VGVGGTGKQSLTRLA | 2446 | Q9C0G6 | |
| SIATLRGFGVGKRGI | 131 | Q16696 | |
| LLVGIGGSGRQSAAK | 2431 | Q8TD57 | |
| KRRGSGRVLVTGSVG | 131 | P14061 | |
| IAVIGGGVSGLSSIK | 6 | P49326 | |
| IVLVGRSGTGKSATG | 441 | Q8ND71 | |
| GTGGTITGIARKLKE | 256 | P35520 | |
| LRGKTVLDVGAGTGI | 81 | Q96LA8 | |
| AGIRTTKGLVRGSLG | 121 | Q96JQ5 | |
| LEKVLGITVSGGRGL | 41 | O60336 | |
| AVGLGVRFIKLGGLS | 536 | A6NNW6 | |
| GHLLLIGVSGAGKTT | 2931 | Q14204 | |
| GYIGRTGKTGTSVTL | 556 | Q86TM3 | |
| LVGTAGTGKSVLVGA | 2476 | Q9NYC9 | |
| GLDRTGLSKVVVGGS | 586 | Q49AJ0 | |
| LVGVGGSGKQSLSRL | 2801 | Q8IVF4 | |
| VGRGKDISTITGHRG | 1046 | Q96T23 | |
| VVTGGSSGIGKCIAI | 36 | Q06136 | |
| GRTAVVTGANSGIGK | 36 | Q6UX07 | |
| STAGLIIGKGGATVK | 181 | P51513 | |
| KIVALVGQSGGGKTT | 501 | Q9NUT2 | |
| EKVGIVGRTGAGKSS | 1321 | P33527 | |
| VGRTGAGKSSLTLGL | 1326 | P33527 | |
| KRVLILGASGGVGTF | 206 | Q8WWV3 | |
| LLGGTRLGSKGDTAV | 566 | Q4VX76 | |
| GKVVVVTGANTGIGK | 41 | Q8TC12 | |
| KVVLTAEVSGGSRGG | 181 | Q99523 | |
| VVGKVVRGGTGLFEL | 1701 | O95602 | |
| AGKGTELAGVTTTGR | 131 | A1A5C7 | |
| AVIIVGSAKVGGLGR | 216 | Q9Y289 | |
| ILGEIKTSGLRGRGG | 76 | P49821 | |
| ELTGAKVVVSGGRGL | 211 | P13804 | |
| VSDGSVKGLLSVVRG | 221 | Q6ZNJ1 | |
| ISGIGKGIIASSVGT | 11 | P17812 | |
| TGGKTQIAGLIGAII | 406 | P40879 | |
| TLHIIKRGDGTGGVT | 121 | Q13046 | |
| VAIVGGSGSGKSTIV | 501 | O75027 | |
| RTLVGLCKLGSAGGT | 481 | Q8IWX7 | |
| ISGIGKGIIASSIGT | 11 | Q9NRF8 | |
| EISKGRTGLGLSIVG | 1631 | O75970 | |
| GIVGGKTSGVVVRTI | 261 | Q8NI35 | |
| GTGTKKVTRILDGGN | 486 | Q9BQI7 | |
| VRVGGKESEVTVGGL | 1416 | P22105 | |
| LVVSGGIVGYVKTGR | 21 | A8MWL7 | |
| GVVSRITGSVGKGLA | 3476 | Q709C8 | |
| LVVSGGIVGYVKTGS | 21 | Q9NUH8 | |
| RTEGGITKGATIGVL | 636 | Q9C026 | |
| TGTGGTAVSRKDRVL | 101 | Q71RG6 | |
| RVVTLGLDGAGKTTI | 406 | P36406 | |
| GIARGGLTGLTLTSL | 176 | O14925 | |
| TVIGRGLKTTDGLAV | 1421 | O75096 | |
| TLKGGTILGTRSLKG | 171 | Q9BWU0 |